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Abstract
Non-hydrogen bonding nucleosides with iodo, nitro, propynyl and thiazolyl 
substituted at the 4-position o f  pyrazole were prepared. These nucleosides were 
converted to their corresponding nucleoside phosphoramidites and incorporated into 
a series o f complementary oligonucleotides in order to determine the effect that 
varying size, charge distribution and polarizability has on duplex stability and 
structure. The self-complementary Dickerson dodecamer sequence 5’- 
CGCXAATTYGCG-3’, as well as the non-self complementary sequence 5’- 
CAAAATGGTGGCCAAGT-3’ previously investigated by Brown, were used to 
determine the duplex stabilization and thermodynamic consequences o f placing 5- 
nitroindole and 4-substituted pyrazole nucleosides across from each natural base. In 
the pyrazole series, the largest and smallest duplex destabilization in all cases 
studied was found with cytosine and adenosine, respectively, while the 4-thiazolyl 
substitution was determined to form the most stable duplex regardless of the 
complementary base. We investigated the directing ability of the pyrazole analogs 
for incorporation of dNTP’s. The DNA polymerases chosen were Taq and Pfu. exo-, 
which lack 3'-5' proofreading exonuclease activity, and Vent, Deep Vent, Pfu which 
contain exonuclease activity. The enzymes were able to incorporate natural 
nucleotides across from our modification as detected using the polymerase chain 
reaction. The Sanger method o f  dideoxysequencing was used to determine the 
natural base incorporated across from the modification. The non-proofreading
xvii
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enzymes mainly incorporated deoxyadenosine across from our modification where 
as the proofreading enzymes removed our modification but not with total efficiency.
Automated DNA synthesis procedures might modifying the 5-nitroindole 
base via electrophilic aromatic substitution by  replacing the nitro group or addition 
o f iodine to the ring system. An alternative oxidation reagent, CSO, was used to 
prepare a series o f  sequences for comparison with sequences prepared using 
standard oxidation conditions. Results from MALDI-MS did not provide conclusive 
evidence for either substitution or iodination o f  the bicyclic ring system.
Examination o f  the thermodynamic results led to the preparation o f thiazole- 
C-nucleoside, which historically is more difficult to synthesize. The thiazole ring 
offers a site for the formation o f  an N-oxide. It has been suggested this group is 
responsible for enzyme recognition. We prepared the thiazole and thiazole-N-oxide 
nucleosides for incorporation into oligonucleotides for thermodynamic and enzymic 
investigations.
xviii
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Chapter 1 
Introduction 
Non-hydrogen Bonding Nucleosides
1.1 Background
The design and synthesis o f  non-natural base analogs was originally sought 
after in hopes o f  a universal base. A universal base is defined as one that would not 
appreciably destabilize the duplex and would pair equally wee with both purines and 
pyrimidines. Also, enzymes would recognize and incorporate equal amounts o f  the 
natural nucleotides (dNTPs) across from the universal base. Incorporation o f all 
bases across from a universal base would allow random mutagensis at directed sites.
3-Nitropyrrole was one o f  the first bases to show almost universal
thermodynamic stability when paired with any of the natural bases. * However, 
polymerase reaction with 3-nitropyrrole showed a large preference for incorporation 
o f purines over p y rim id in es.^  Thus another application o f this type o f  nucleoside 
analogs is for directed conversion o f  one base to another.
Often mismatches have to be created when attempting to convert one base 
pair to another (e. g. GC bp AT bp). A  G-T “wobble” mismatch in the primer 
results in reduced polymerase extension efficiency (poor read) and thus low 
efficiency o f  conversion. As shown with the use of a non-natural base could 
improve this by eliminating the poor read step as the analog could pair well 
(Watson-Crick bonding pattern) with the natural base, unlike the wobble mismatch. 
The resulting “good read” would improve the overall conversion o f  the sequence.
One application o f  polymerase-based conversion with nucleobase analogs is 
creation o f restriction sites in DNA for enhancing detection o f low level mutations
l
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
in a large background o f  wild-type (non-mutated) DNA-3*4 The introduction o f 
non-natural base into a  PCR primer will allow for conversion o f the sequence to 
generate a restriction site in wild type DNA while the low-level mutant DNA will 
not posess a restriction site. Following this PCR step (repeating many times if 
necessary), a restriction enzyme will digest the DNA removing the converted wild- 
type DNA and leaving the mutant DNA uncut.3*4
y — C' - 3' y — t y — t— ■ -3- y — t
3" ----- G- ----------y
J  94 PC 65 »C |  Taq Pol 65 PC J  Taq Pol 65 PC J  Taq Pol
y — c- y — t — ^ y — t -3’ y —  t —
3’ ----- G  — - -y -y
3’ ----- G-
^  94 PC ^  94 PC
y ---- r --------- -  3' y — t * 3'
• y -y
H C M , O  M
C H , 0 - « - N  N
f t , - h -n H -1  --------------- ^  ~ M.  , ............... ,  ,  f  Vh-n^Vm
,H~ i  > =N  R R O — H - N y - M ,  N - ^
R O — f  )= N  R R O
H -H  G  T  A
H
5’  C -  - 3 ’ 5'  06  y  ——Q * ^ ———  3' y  — T
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1.2 Design
The introduction o f  non-natural nucleosides has been under intense 
investigation as a way to understand the extremely efficient design o f DNA and its 
properties. We and others are interested in dissecting the roles hydrogen bonding 
and “base stacking” play in controlling duplex stability, structure, and DNA 
enzymology. One approach to studying these factors is to remove the hydrogen 
bonding o f  the bases altogether. A first foray into this approach was replacing the
heteroaromatic bases with either a hydrogen atom or a phenyl ring,5 which found 
that both substitutions were similarly destabilizing to the duplex. The pioneering 
work o f Bergstrom and coworkers used an intercalation model to develop a 3- 
nitropyrrole a n a l o g ,^> 7  which had much great stability in a duplex relatively to the 
Millican phenyl or abasic site analogs.^
Another approach is to mimic the size and charge of the natural nucleosides 
as Kool and coworkers have suggested. They designed 2,4-difluorotoluene as a 
shape mimic o f thymidine.8>9 The methyl group is in same position and the fluoro 
groups are similar to the oxygens on thymidine both in size and electronegativity. 
Kool also designed 4,6-dimethyindole as a  hydrophobic adenine analog.8>9(Figure 
1.5) The methy groups are in the proximity o f  the oxygens in T to offer similar 
shape without specific hydrogen bonding characteristics.
We have developed a series non-hydrogen bonding analogs (Figure 1.2) to 
investigate the properties o f  DNA when hydrogen bonding is removed while 
varying the charge and size characteristics o f  substituents on the aromatic core. We 
designed a series of pyrazole analogs with substituents in the 4-position with
3
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varying charge and size, iodo, propynyl, nitro and thiazolyl (2a, 2b, 2c, and 2e). 
The differing characteristics o f  the substituents allows for investigation o f  charge 
distribution and size variation on the stability o f  DNA duplexes as well as the 
enzymic acceptance o f  the analogs. The size o f  the small 5-membered should fit 
into the active site o f  enzyme and not offer steric hindrance when incorporated 
across from purines.
NO;
V N V N HO HO
HO HO HO HO
P z l P zN  P zP  P zT
2 a  2b 2c 2 e
Figure 1.2 Series of pyrazole analogs
1.3 Synthesis
Once the series o f  pyrazole analogs was chosen, the synthesis o f these non­
natural analogs had to be designed. There are two traditional approaches for the 
synthesis o f  nucleosides. The first and more popular approach uses the 
corresponding base analog reacting with a sugar resulting in the nucleoside. This 
type o f  reaction is called glycoslyation. The Hilbert-Johnson method is a classic
glycosylation method used in the synthesis o f  Nl-glycosyl p y r i m i d i n e s . ^  The 
second approach requires the construction o f  the base analog system from an N or 
C-glycoslated precursor. There are 2 different types o f nucleosides, C or N. We are 
interested in the synthesis N-nucleosides. Meaning, the Cl position o f  the sugar is 
attached to the bases through a nitrogen in the ring o f  the base (Figure 1.3). The
4
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other type is a  C-nucleoside. These have the sugar attached to a carbon in the ring 
o f  the base. C-nucleosides are much more difficult to synthesize. This difficulty
arises from the unstable precursors, like glycals^  or a low yielding multistep 
reactions which builds the aryl unit from a cyano or some other C-glycoside (Figure 
1.3). We are interested in attaching the N1 o f  the commercially available pyrazole 
ring to the sugar precursor. The substituents are either already present on the ring 
when purchased (iodo and nitro) or they are synthesized (propynyl and thiazolyl) 
once the pyrazole ring is attached to the sugar using palladium mediated chemistry.
r= \
To,0n / \ , N'    ToIO- v o Y n
To|o Cl Toio
TolO
N-nucleoside C-nucleoside
Figure 1.3 N-nudeoside and C-nucleoside synthesis
1.4 Thermodynamic Stability
The arrangement o f  the aromatic bases in DNA orthogonally, along the 
center axis o f  the duplex allows pyrimidine-purine hydrogen bonding between the 
two strands (edge-edge interactions) as well as stacking o f  bases with the bases 
above and below it in the duplex (7c-tc interactions). After removal o f  hydrogen 
bonding, a heterobase analog utilizes mainly ir-stacking along the axis o f  the duplex, 
though dipole-dipole interactions across the duplex with its putative ‘‘pairing” 
partner may also influence structure and stability of the duplex.
One factor that affects stacking ability is the charge distribution in the 7t- 
aromatic system o f the analog. For example, 3-nitropyrrole (Figure 1.5) is much
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less destabilizing than a phenyl ring. 12 Bergstrom showed that an unsubstituted
pyrazole ring which has some charge distribution is equivalent to an abasic s i t e .  13 
The addition o f  a nitro group to the 4-position o f  the pyrazole ring dramatically 
increases the stability o f  the helix by 10-20 °C.13
Figure 1.4. Comparison of hydrogen bonding base pair with a non-hydrogen 
bonding analog.
A second factor affecting stacking ability is size. This is demonstrated by 
the increased stability o f duplexes with 5-nitroindole (Figure 1.5) over 3-
nitropyrrole by approximately 20 °C.13 in a similar vein, Froehler has shown 
propynyll4 and th iazolyl^  substituents, on hydrogen bonding bases, stacking in the 
major groove can increase the duplex Tm by 1-2°C per substitution. (Figure 1.6)
3-Nitropyrrole 5-Nitroindole 4,6- Dimethylindole 2,4-Difluorotohiene
Figure 1.5 Structures of analogs studied by Bergstrom/* Brown,12 and Kool9
The size and charge distribution o f the non-hydrogen-bonding analog also 
has an effect on the preferred pairing partner when investigating duplex stability. 
For example, Bergstrom and coworkers have found 3-nitropyrrole base analog to be 
less destabilizing to the duplex when “paired” with deoxyadenosine (A) and
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deoxygaunosine (G) ^  Whereas, the 5-nitroindole nucleoside base analog is less 
destabilizing when paired with deoxycytidine ( Q . ^  Kool has investigated several
analogs (Figure 1.5) such as 4,6-dimethylindole and 2,4-difluorotoluene, while 
diflourotoluene is a deoxythimidine (T) analog it is least stable across from A and in
fact is most stable across from itself in the duplex.^
To determine the stacking ability o f a variety o f  substituents without 
hydrogen bonding effects, we have prepared a series o f  4-substituted pyrazole 
nucleoside analogs and studied their effects on DNA duplex stability in a variety of 
contexts.
1.5 Enzymic Activity
1.5.1 DNA Polymerases
DNA polymerases are responsible for the replication o f  DNA. Komberg 
isolated the first DNA polymerase in 1955 from an extract o f E. coli. This 
polymerase, now called DNA polymerase I, has two main segments with three main 
functions. The N- terminal small fragment contains 5'->3' exonuclease activity. 
Exonuclease activity is the ability o f a polymerase to remove an imperfect match. 
The large fragment, better known as the Klenow fragment, has polymerase activity 
as well as 3'->5' exonuclease activity. These three functions are crucial to correct 
replication o f DNA.
Figure 1.6 Structures o f thymidine, 5-(l-propynyl)-2’deoxyuridine and 5-(2- 
thiazoyl)-2’-deoxyuridine
o
HO
R= — C H , . *CH j  . o r
7
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Replication o f  DNA, also called extension o f  a primer, involves several 
components. First, the enzyme must posses polymerase activity. The sequence to 
be copied, called the template, must be present. Next, a primer (much shorter in 
length) matching a portion o f  the template sequence must anneal to the template 
making a double strand o f  DNA. For the polymerase to extend o ff the 3'-end o f the 
primer, deoxynucleotide triphophates must be availble to the polymerase and an 
optimal temperature reached for extension to begin. Once these main components 
are present, replication o f  the template is possible.
1.5.2 Polymerase Chain Reaction (PCR)
The introduction o f  the polymerase chain reaction (PCR) revolutionized 
DNA extension technology. 1'6,17(Figure 1.8) This tool allowed for rapid 
amplification o f  finol quantities o f DNA. Whereas the previous extension 
technology (Figure 1.7) only provided linear amplification. The concept is similar 
to that described in Section 1.5.1 but the cycle is repeated many times varying the 
temperature to allow for annealing o f  the primer, extension and denaturing o f the 
double stranded product. Also the product is increased exponentially due to the 
presence o f a double stranded template and a primer for each strand o f the double­
stranded template. The extension explained earlier only required a single stranded 
template and one primer. The desired double stranded sequence to be amplified is 
called the template. The template is normally present in finol quantities. At least 
some o f the template sequence must be known so as to offer a  place for annealing o f 
the primer so that amplification can occur. The primers serve as the starting place 
for the DNA polymerase to start copying the template. A primer must be designed
8
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P rim er
S tra n g
C iN T P
Figure 1.7 Polymerase extension
PCR Amplification of ds DNA
separate strands bv healing to 95-C
Anneal p rim ers by  cooling to 37°C
H eat to 70°C to allow  for exicastion
SI ’C
Anneal prim ns by cooling to 37°C
Hear to 70°C to allow forex tenstion
Repeat There are now four sets of double 
strandedfds) template where only one set was 
used to start. The third round of PCR will
provide 8 sets of ds template, 16,32 e tc .
Figure 1.8 PCR amplification cycle
9
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97
for each strand o f  the template. Once the reaction starts, the primers are extended 
in the 3' ->5' direction to the end o f both strands o f the template. The polymerase 
inserts the complementary dNTP that creates a natural base pair w ith the template 
strand and then continues on to the next base. At the completion o f this cycle, a 
copy o f the original template is created. The double stranded products are separated 
by heating to 95 °C and now a place is available for new primers to be positioned 
for extension. To position the primers on the template an annealing step is 
performed (normally 50-60 °C) followed by raising the temperature to 70-75 °C 
(depending on polymerase) for optimal extension temperature. On the second cycle, 
copies o f old and new pieces o f  template are made resulting in a total of four 
templates. The third cycle copies the four strands resulting in a total o f eight and so 
the template is amplified exponentialyl.
The Klenow fragment was not particularly efficient for PCR as the high heat 
required in thermal cycling kills the polymerase activity o f the enzyme. Therefore 
the discovery o f thermostable polymerase was necessary for the success o f PCR. 
The thermostable polymerase under the most intense investigation was Thermus 
aquaticus (Taq). * 8-21 Other thermostable polymerases that are commonly used are 
Thermotoga maritima (T m a )^ , Pyrococcus furiosus (P fup3-25t Thermus 
thermophilus (Tth) 26,27} Pyrococcus species GB-D 28 (Deep Vent from New
England Biolabs) and Thermococcus litoralis (Tli) 29 (Vent from New England 
Bioiabs). These polymerases as well as many others provide different tools for 
investigating modified primers, modified triphosphates or modified templates.
10
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1.5.3 Sanger M ethod for Sequencing DNA
The Sanger method is very similar to PCR in the fact that a polymerase, a 
primer, a template and dNTP’s are used. (Figure 1.9) This technique only provides 
linear amplification o f the desired product. What makes this method different is 
there are dideoxy nucleotide triphosphates (ddNTP’s) present. ddNTP’s lack the 3 ' 
hydroxyl group removing the active group for extension. This creates truncated 
pieces that have been extended somewhat but once the ddNTP is incorporated no 
extension is possible. For the convenience o f  determining the ddNTP that 
terminates the strand the ddNTP’s are radiolabeled with 33P for the purpose of 
imaging the truncated sequences. (Figure 1.9) Each o f the four natural bases are 
used as ddNTPs but in separate reaction so as to be able to determine the exact 
sequence. Once the extension reaction is complete, the truncated pieces are loaded 
onto a polyacryamide gel to be separated using gel electrophoresesis based on 
differences in size. The shorter pieces move at a faster rate through the gel as the 
longer pieces move at a slower rate. Once the electrophoresis is complete, a ladder 
o f the different sized pieces is present. Each separate reaction with an individual 
ddNTP is loaded in individual lanes and separated at the same time. This creates a 
ladder o f the different sized pieces and allows for determination o f the 
sequence.(Figure 1.9) An alternative method for sequencing is the Maximum- 
Gilbert method. This required chemical degradation with regents specific for one or 
two o f the natural bases followed removal o f  the base creating an abasic site along 
the backbone o f  the DNA. Once the abasic cite is present cleavage o f the backbone 
is much easier resulting in truncated sequences as well.
11
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Figure 1.9 Sanger method for dideoxy sequencing
1.5.4 Exonuclease Activity
There are two directions for exonuclease activity to occur 3 '-> 5 ' and 5 '->3 
5 '-> 3 ' Exonuclease is useful in removing misprinted sequences and to repair
damaged nucleotides.^  The 3 '-> 5 ' activity can remove unnatural modification by 
cutting up the DNA until the unnatural analog is removed. W ith 3'->5' exonuclease 
activity, also known as proofreading, the enzyme can remove an incorrectly inserted 
nucleotide at the primer terminus or 3'-end before continuing with 
polymerization.(Figure 1.10) The mismatched nucleotide is not involved in 
hydrogen bonding with the template strand. The ability to proofread drastically
12
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increases the accuracy o f the DNA replication by allowing the polymerase to correct 
any mistakes before continuing.
—6- - -  e
3'OH
5'
Figure 1.10 3'->5* Exonuclease activity-proofreading
5'-> 3' exonuclease activity allows the polymerase to excise any misprimed 
sequences and continue with polymerization. (Figure 1.11) Without this feature, the 
polymerase would discontinue polymerization o f the template when misprimed 
sequences were found (most often in nature with RNA primers). W ithout this 
activity, DNA replication is not as accurate and complete replication o f the template 
is hindered.
13
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1.5.5 Polymerase Reactions with Non-Natural Nucleosides
The behavior o f enzymes with non-natural nucleosides has drawn much 
attention and research. Bergstrom reported one o f the first successfid PCR reactions 
using a modified primer containing 3 n itrop yrro leA ^  Other work by Bergstrom 
utilizing azole nucleobase analogs provided the model for our experiments.^ 
Bergstrom’s research studied 3-nitropyrrole, inosine, 3-pyrrolecarboxamide, 4- 
pyrazole-carboxamide and 4- imidazolecarboxamide, along with an abasic site with 
PCR utilizing Taq DNA polymerase. (Figure 1.12) These results showed a 3:1 A:T 
incorporation in PCR for 3-nitropyrrole using the Sanger sequencing method with 
33P radiolabeled dideoxyterminators. Sim ilar research by Kool and coworkers uses 
2,4-diflorotoulene (DFT) as a T mimic. Kool has successful incorporation o f DFT 
triphosphates across from A and incorporation o f dATP across from DFT analogs in
14
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Figure 1.12 Structures o f 3-nitropyrrole, 3-pyrroIe-carboxamide, 4-pyrazole- 
carboxamide, 4-imidazole-carboxamide, and inosine (left to right)
dihydropyrimido[4,5-c][l,2]oxazin-7-one, a pyrimidine analog, and N^-methoxy-
results with these modification incorporated into a primer using Taq polymerase 
show these analog behave as designed a purine analog, K and a pyrimidine analog, 
P. The research o f Bergstrom^ and Brown^ 1 has shown the ability o f Taq 
polymerase to accept a non-natural nucleobase in the DNA primer as well as non­
natural triphosphates.
Figure 1.13 Structures of 6H, 8H-3,4-dihydropyrimido[4,5-c][l,2]oxazin-7- 
one (P) and N6-methoxy-2,6-diaminopurine (K)
Our research w ill investigate the acceptance o f the pyrazole analogs with Taq 
DNA polymerase as well as other thermostable polymerases with a variety o f 
inherent properties using PCR. We will also investigate how the pyrazole analogs 
are read by the enzymes using sequencing methods to determine the natural base 
incorporated across from the analogs.
primers.^(Figure 1.5) Brown and coworkers have used 6H, 8H-3,4-
2,6-diaminopurine, a purine analog, P and K respectively.3 1 (Figure 1.13) The
R
P K
15
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
1.6 References
1) Zhang, P .; Johnson, W. T.; Klewer, D.; Paul, N.; Hoops, G.; Davisson, V. J.; 
Bergstrom, D. E. Nucleic Acids Res. 1998,2 6 ,2208-2215.
2) Hoops, G. C.; Zhang, P.; Johnson, W. T.; Paul, N.; Bergstrom, D. E.; Davisson, 
V. J. Nucleic Acids Res. 1997,2 5 ,4866-4871.
3) Day, J. P.; Hammer, R. P.; Bergstrom, D.; Barany, F. Nucleic Acids Res 1999, 
27, 1819-1827.
4) Day, J. P.; Bergstrom, D.; Hammer, R. P.; Barany, F. Nucleic Acids Res 1999, 
27, 1810-1818.
5) Millican, T. A.; Mock, G. A.; Chauncey, M. A.; Patel, T. P.; Eaton, M. A. W.; 
Gunning, J.; Cutbush, S. D.; Niedle, S.; Mann, J. Nucleic Acids Res. 1984, 12, 
7435-7453.
6 ) Nichols, R.; Andrews, P. C.; Zhang, P.; Bergstrom, D. E. Nature 1994,369, 
492-493.
7) Bergstrom, D. E.; Zhang, P.; Toma, P. H.; Andrews, P. C.; Nichols, R. J. Am. 
Chem. Soc. 1995,117, 1201-1209.
8 ) Schweitzer, B. A.; Kool, E. T. J. Org. Chem. 1994, 59, 7238-7242.
9) Schweitzer, B. A.; Kool, E. T. J. Am. Chem. Soc. 1995,117, 1863-1872.
10) Pliml, J.; Pyrstas, M .;. Adv. Heterocyc. Chem 1967, 8 ,115.
11) Cameron, M. A.; Cush, S. B.; Hammer, R. P. J. Org. Chem. 1997, 62, 9065- 
9069.
12) Loakes, D. Nucleic Acids Res. 1994, 22, 4039-4043.
13) Bergstrom, D. E.; Zhang, P.; Johnson, W. T. Nucleic Acids Res. 1997, 25, 
1935-1942.
14) Froehler, B. C.; Wadwani, S.; Terhorst, T. J.; Gerrard, S. R. Tetrahedron Lett. 
1992, 33, 5307-5310.
15) Guiterrez, A. J.; Terhorst, T. J.; Matteucci, M. D.; Froehler, B. C. J. Am. Chem. 
Soc. 19 9 4 ,116, 5540-5544.
16) Mullis, K. B.; Faloona, F. Meth. Enzymol. 1987,155, 335-350.
17) Saiki, R. K.; Gefland, D. H.; Stoffel, S.; Scharf, S.; Higuchi, R.; Horn, G. T.; 
Mullis, K. B.; Erlich, H. A. Science 1988,239,487-491.
16
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
18) Chein, A.; Edgar, D. B.; Trela, J . M. J. Bacteriol. 1976,127,1550-1557.
19) Kaledin, S. S.; Sliusarenko, A. G .; Gorodetskii, S. I. Biokhimiya 1980, 45, 644- 
651.
20) Lawyer, F. C.; Stoffel, S.; Saiki, R. K.; Myambo, K.; Drummond, R.; Gefland, 
D. H. J. B io l Chem. 1989,2 64 ,6427-6437.
21) Longley, M. J.; Bennett, S. E.; Mosbaugh, D. W. Nucleic Acids Res. 1990,18, 
7317-7322.
22) Bost, D. A.; Stoffel, S.; Landre, P.; Lawyer, F. C.; Akers, J.; Abramson, R. D.; 
Gefland, D. H. FASEB J. 1994, 8, A1395.
23) Lundberg, K. S.; Shoemaker, D. D.; Adams, M. W.; Short, J. M.; Sorge, J. A.; 
Mathur, E. J. Gene 1991,108, 1-6.
24) Mathur, E. J.; Adams, M. W.; Callen, W. N.; Cline, J. M. Nucleic Acids Res. 
1991,19, 6952.
25) Uemori, T.; Ishino, Y.; Toh, H.; Asada, K.; kato, L. Nucleic Acids Res. 1993, 
21.
26) Ruttimann, C.; Cotoras, M.; Zalvidar, J.; Vicuna, R. Eur. J. Biochem. 1985,
149, 41-45.
27) Carballeira, N.; Nazabal, M.; Brito, J.; Garcia, O. BioTechniques 1990, 9, 276- 
281.
28) Perler, F. B. unpublished data, 1994.
29) Perler, F. B.; Comb, D. G.; Jack, W. E.; Moran, L. S.; Qiang, B.; Kucera, R. B.; 
Benner, J.; Slatko, B. E.; Nwankwo, D. O.; Hempstead, S. K.; Carlow, C. K. S.; 
Jannaach, H. Proc. Natl. Acad. Sci. U.S.A. 1992, 6+, 5577-5581.
30) Komberg, A.; Baker, T. A. DNA Replication-, Freeman: New York, 1992.
31) Hill, F.; Loakes, D.; Brown, D. M . Proc. Natl. Acad. Sci. USA 1998, 95 ,4258- 
4263.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Chapter 2
Synthesis of Pyrazole containing Nucleobase Analogs and 
Incorporation into DNA oligonucleotides
2.1 Synthetic Design o f Pyrazole Nucleosides
H3c
HO HO
HO HO HO HO
P zl PzN P z P  PzT
2a 2b 2c 2e
Figure 2.1 Target pyrazole nucleosides
For N-glycosides, our synthetic approach, sim ilar to Bergstrom, 1 uses a 
chloro group as the leaving group . 1 Nucleophilic attack on the C l position by N1 
o f the pyrazole displaces the chloro and results in the pyrazole nucleoside. Iodo and 
nitro substituents on the 4 position o f pyrazole are available commercially. 
Palladium mediated chemistry is used to convert iodo into propyne and thiazole 
substituents. The propyne is directly converted using Pd catalyzed chemistry
introduced by Robins.^ The thiazole group is attached via a  tin  intermediate
following Stille type coupling methods used by Froehler.^ An initial approach to le  
involved stannlyation o f 2 -bromothiazole using n-butyl lithium  and 
tributyltinchloride, but attempts to isolate 2 -tributyltin-thiazole away from the tin
byproducts proved difficult by distillation.^ Therefore the tin group was introduced
18
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to the iodonucleoside and coupling o f the thiazole to  the pyrazole-nucleoside proved 
more effective.
The natural nucleosides offer a charge distribution about the heterocyclic systems 
(Figure 2.2). The charge distribution not only offers electrostatic attractions across the 
base pairs but also between base pairs along the axis o f the helix. The natural bases also 
offer large aromatic systems, which are capable o f Tt-stacking, meaning favorable 
interactions between the large 7t-clouds along the center o f the helix.
Figure 2.2 Charge Distribution in Natural Base Pairs
The pyrazole analogs were designed to offer both charge distribution and the 
ability to stack. By varying the type of substituents, the importance of each contribution 
might be better understood. The thiazole ring offers a 7t-system for stacking as well as 
positive and negative centers for charge distribution. The propynyl unit offers tr-stacking 
and the nitro unit offers a large negative center while the iodo group offers similar size 
but not the same charge or7t-system (Figure 2.3).
C-G Base Pair A-T Base Pair
HH H H
P zl PzN PzP PzT
Figure 2.3 Charge Distribution of Pyrazole Analogs
19
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
2.2 Synthesis o f  Nucleosides
4-Iodopyrazole and 4-nitropyrazole toluoyl protected nucleosides (la  and 
lb ) were synthesized by treating the appropriate pyrazole (4-iodopyrazole or 4- 
nitropyrazole) w ith NaH followed by addition to 3,5-bis-0-p-toluoyl-P-D-2-
deoxyribose chloride (Scheme2.1)^ in 72% to 86% yield (Scheme 2.2). 4-Propynyl- 
pyrazole nucleoside was prepared from la  by treatment with propyne gas,
Pd(Cl2XPPh3)2, triethylam ine and copper iodide in 60% yield .2  When water is not 
rigorously excluded, then a reduction o f 4-iodopyrazole la  to an unsubstituted 
pyrazole nucleoside is observed (see experimental section for details). 4-(2- 
Thiazolyl) pyrazole nucleoside (le ) was also made from la  by conversion to 4- 
(trim ethyldn) pyrazole tolouyl protected nucleoside (Id ) (8 6 %) followed by 
coupling with 2 -bromothiazole using Pd(PPh3)4 (60%).^
This final synthetic approach for le  deserves some further comment. As 
mention in Section 2.1, introduction o f the tin group directly to the thiazole did not 
prove to be effective. Inverting the approach by introduction o f the tin group to the 
nucleoside allowed purification o f the tin intermediate Id  by flash chromatography 
in excellent yield (8 6 %). However, care must be taken to avoid protodestannylation 
o f the nucleoside on the silica column, which again results in an unsubstituted 
pyrazole nucleoside, by the use o f triethylamine (0.5%) in the eluant. Addition o f 
the tin  moiety to the nucleoside in our hands worked best in a  non-polar solvent like 
toluene and the thiazole coupling required a polar solvent to provide any thiazolyl- 
pyrazole product (DMF yeilds 50-60%, dioxane yeilds 10-20%).
20
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The free nucleosides, 2a, 2b, 2c, and 2e, were synthesized by treatment o f 
the toluoyl protected nucleosides with methanol saturated with ammonia. The free 
nucleosides were then prepared for incorporation into DNA oligomers by utilizing 
standard chem istry to achieve the dimethoxytrityl-protected phosphoramidite (4a, 
4b, 4c, 4e) (Scheme 2.3)6
Scheme 2.1 Synthesis o f 3,5-bis-0-p-toluoyl-P-D-2-deoxyribosyl chloride
HO—| n  Pyridine TolO-
OH
HCl/MeOH
OH HjC - ^ - I l c |
pToI-Cl
OTol
HCVAcOH
OTol
Scheme 2.2 Synthesis of 4-snbstitued pyrazole protected nucleosides
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Scheme 2.3 Synthesis o f 4-substitnted pyrazole phosphoramidite for 
incorporation into oligom ers using automated DNA synthesis
x x X
TolO la-c ,e
DMTO
> x- I
b X -  N O , 
c X - PROPYNL 
e X -  2-THIAZOLYL
A. * U
^OOCH,
OCH 3 DMTO
X J
DMT =
O
Tol -  —C
CN
4a-c,e
Reagents: (i) NH3(sat.) MeOH; (ii) dimethoxytrityl chloride, DMAP, DIEA, DCM; 
(iii) 2-cyanoethyl N,N-diisopropylchlorophosphoramidite, pyridine
2.3 Incorporation o f Nucleosides Analogs into DNA Oligomers
2.3.1 Solid Phase DNA Synthesis
Solid phase DNA synthesis (Scheme 2.4) is the most practical and efficient 
method for incorporation o f  the modified bases. This method is rapid and simple. 
Utilizing the phosphoram idite method for synthesizing o l i g o m e r s  ^ (Scheme 2.4), the 
reactive phosphorous (EH)® on the 3' end o f one base couples w ith the free S'
hydroxyl o f a tethered nucleoside. Control Pore Glass (CPG)9 beads are used as the 
solid support w ith the first base attached through a succinate ester linkage which is 
base labile. The natural bases are protected using base labile protecting groups such 
as benzoyl. (Figure 2.4) These protecting groups are cleaved once the synthesis is 
complete at SS °C for 8 hours in ammonium hydroxide. The S' hydroxyl o f the
incoming base is protected w ith dimethoxytrityl, an acid labile group .6  The acid
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labile protecting group is removed using mild acid. The next step requires the 
coupling o f the activated 3'-P(HI) center o f the incoming base to the free 5'OH o f
the tethered using tetrazole as the activating species. 10 Once the coupling o f the 
new base with the tethered base is complete, a capping step is performed using 
acetic anhydride to block any unreacted hydroxyl groups from reacting in later 
steps, thus avoiding the creation o f deletion sequences. Once the capping step is 
complete. The P(IH) center is oxidized to P(V) using aqueous iodine. This cycle is 
repeated n times until the desired sequence is synthesized. Cleavage o f the oligomer 
o ff the support requires the used o f  ammonium hydroxide for periods o f 15 minutes. 
Once removed from the support the base protecting groups are removed at 55 °C for
8 h.
o
DMTODMTO
CN
d Cbz T
O
DMTODMTO
Figure 2.4 Phosphoramidites used in solid phase synthesis
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Scheme 2.4 Solid phase DNA synthesis, phosphoramidite method
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2.3.2 Preparation o f Oligonucleotides with Analogs
Incorporation o f the pyrazole analogs into DNA strands was done using 
standard automated DNA chem istry. (See Sections 3.3 and 4.7.1.3 for sequences 
synthesized.) Oligodeoxyribonucleotides were prepared from commercially 
available dA, dC, dG, dT (ABD-PE) and 5-nitroindole phosphoramidite (Glen 
Research) on an A B I394 synthesizer using standard solid phase phosphoramidite 
chem istry (1 pm ol scale). An alternative oxidation method (Chapter 6 ) was used 
with long sequences containing 5-nitroindole. Stepwise coupling yields ranged from 
80 to 100%. The 5-O-DM T protected oligonucleotides were synthesized and 
cleaved o ff the Control Pore Glass (CPG) column using ammonium hydroxide. The 
protecting groups for the natural bases were removed by ammonium cleavage at 55 
°C for 8 hours. The crude reaction mixture was then purified using “trityl on” 
purification techniques with Oligopurification Cartridges (OPC) from ABI-Perkin- 
Elmer according to the m anufacture's instructions. The eluant was checked for 
purity by reverse phase o r anion exchange high performance liquid chromatography 
(HPLC). In some instances the oligom er was purified using preparative anion 
exchange HPLC. Anion Exchange HPLC was performed using a Hydrocell 
NS1000 polymeric column 4.5 x 150 mm on a  Perkin Elmer Series 200 HPLC with 
785A UV/VIS detector at 260 nm. Characterization was also by MALDI mass 
spectrometry (PerSeptive Biosystems Inc, Voyager Linear MALDI-TOF w ith N2 
laser and ammonium citrate matrix).
25
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2.3.3 Calculation o f Extinction Coefficient
The extinction coefficient for each o f  the unprotected nucleosides (nitro, 
iodo, propynyl and thiazolyl) was determined using a Beer's Law plot o f the 
absorbance (260 nm) at each o f  5 known concentrations. The extinction coefficient 
o f 5-nitroindole is 15,296 M*1 cm '1. H
Table 2.1 Extinction coefficient for each unprotected pyrazole nucleoside
Compound Extinction coefficient
M'1 cm'1
Ind 15,296
(2a) Pzl 285
(2b) PzN 5810
(2c) PzP 954
(2e) PzT 6927
2.4 Experimental
Compounds 2a, 3a, 4a, lb , 2b, 3b, 4b, 2c, 3c, and 4c were synthesized by 
either M elissa Cameron or Tod M iller for incorporation into oligomers
2.4.1 (2'-Deoxy-3', 5'-bis-£?-/MoIuoyl-P-D-ribofuranosyl)-4-iodopyrazole (la) 
Procedure A: To an oven dried two neck flask containing 4-iodopyrazole (6.48 g,
33.4 mmol), acetonitrile (30 mL) was added under Ar by cannulation, cooled to 0 
°C, followed by addition NaH (1.01 g, 42.1 mmol). Once the solution ceased 
bubbling, 3, 5-bis-0-p-toluoyl-[}-D-2-deoxy-ribofuranosyl chloride^ was added 
(13.0 g, 33.7 mmol) and the solution was stirred under A r and allowed to warm to 
room tem perature overnight The solution was concentrated under reduced pressure
26
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and purified by silica column (2:3 hexanes-Cf^C^) to yield 13.3 g (72%) o f a white 
solid, m.p. 110 °C; TLC: Rf= 0.66 (2:1 hexanes-EtOAc); FABMS (Glycerol) 
Theoretical 547.3 (M+H)+, Found 547.3 (M+H)+; 'H  (250 MHz, CDC13), 7.94 (d, 
JAr=4.1, 2H, Ar), 7.91 (d, J at= 4 .2 , 2H, Ar), 7.64 (s, 1H, H5), 7.54 (s, 1H, H3), 7.27 
(d, J at= 2 .9 , 2H, A t) , 7.22 (d, Jat= 7 .8 , 2H, Ar), 6.20 (t, J h2=6-2, 1H, H I'), 5.75 (dd, 
J=2.8, J=5.9, 1H, H3'), 4.63-4.49 (m, 3H, H4 and H5), 3.20-3.09 (m, 1H, H2’), 2.66 
(ddd, J= 3 .7 ,6 .2 ,9 .8 ,1H, H2’), 2.42 (s, 3H, CH3), 2.41 (s, 3H, CH3); 13C (75 MHz, 
CDCl3) 6,166.17 (C (0)), 165.82 (C (0)), 145.23 (C5), 144.26 (C(O)-Ar), 143.82 
(C(O)-Ar), 133.19 (C3), 129.66 (Ar), 129.11 (Ar), 126.83 (Ar-CH3), 126.55 (Ar- 
CH3), 89.84 (C l’), 82.84 (C4'), 75.06 (C3'), 64.03 (C5'), 37.41 (C2'), 21.66 (CH3); 
Anal. Calc’d for C24H23lN205: C 52.76, H 4.24, N  5.13,. Found: C 52.57, H 4.50, N 
5.11.
2.4.2 (l-(2'-Deoxy-P-D-ribofuranosyl)-4-iodopyrazoIe (2a)
Procedure B: Deprotection o f 1 -(2'-deoxy-3',5'-bis-0-p-toluoyl-p-D-ribofuranosyl)- 
4-iodopyrazole ( la )  (2.08 g, 3.82 mmol) using ammonia saturated methanol (100 
mL) overnight. The solvent was removed under reduced pressure followed by flash 
chromatography (4:5 CHiCb-EtOAc) to yield a yellowish oil (1.01 g, 86%). TLC: 
Rf=0.39 (9:1 CHCl3-CH3OH); UV-Vis: £260 =285 M^cm*1; FABMS (Glycerol) 
Theoretical 311.1 (M+H)+, Found 311.3 (M+H)+; lH (250 MHz, CDC13) 5 7.60 (s, 
1H, H5), 7.59 (s, 1H, H3), 6.11 (t, J h2=6.4 , 1H, HI*), 4.74 (dd, J=2.7, 5 .6 ,1H, H3’),
4.13 (app. d, J=2.4,1H , H4’), 3.88 (dd, JH4-=2.0, ^ 5= 12 .6 , 1H, H5'), 3.72 (dd, 
J h4-=2.0, J hs-= 12 .6 , 1H, H51), 2.89-2.78 (m, 1H, H 2'), 2.41 (ddd, J= 3.l, J=6 .8 , 
J=13.8, 1H, H2'). 13C (62.5 MHz, CDCI3) 8  145.78 (C5), 134.11 (C3), 89.92 (C l'),
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89.04 (C4’>, 72.72 (C3’), 63.36 (C5’>, 41.64 (C2'); Anal, calc’d for C8HUN2 0 3: C 
30.99, H 3.58, N  9.03, Found: C 30.75, H 3.80, N  9.05
2.4.3 1 -(2 '-Deoxy-5 '-dimethoxytrityl- P- D-ribofuranosyl)-4-iodopyrazole (3a)
Procedure C: l-(2'-Deoxy-P-D-ribofuranosyl)-4-iodopyrazole (2a) (0.999 g, 3.23 
mmol) was coevaporated with 2  portions o f pyridine then dissolved in pyridine (10  
mL). Next addition o f DMAP (0.424 g, 3.47 mmol) was followed by DIEA (8  mL) 
and DMT-C1 (1.05 g, 3.09 mmol). The reaction was left stirring overnight under 
inert atmosphere. Purification o f the crude product by flash chromatography 
yielded 1.45 g (73%) o f  oil. m.p. =  35 °C; TLC: Rf=0.34 (4:3:1 hexanes-EtOAc- 
Et3N); FABMS (NBA) 612.6 (M)+; lH (200 MHz, CDC13) 6 7.64 (s, 1H, H5), 7.46 
(s, 1H, H3), 7.40 (app. d, J=8.0,2H , Ar), 7.24-7.16 (m, 7H, Ar), 6.80 (app. d,
J=8.2,4H , Ar), 6.09 ( app. t, Jh2-=5 .1, 1H, H I'), 4.62-4.57 (m, 1H, H3'), 4.19 (app. 
dd, J=4.2, J=8 .8 , 1H, H4'), 3.78 (s, 6 H, OCH3), 3.34-3.17 (m, 2H, H5’ & H5"), 2.79- 
2.67 (m, 1H, H 20,2.57-2.438 (m, 1H, H2”); Anal, calc’d for C29H29IN2O5: C 56.87, 
H 4.77, N 4.57, Found: C 56.71, H 4.89, N  4.61
2.4.4 1 -(2 '-Deoxy-5 '-dimethoxytrity 1-3 '-0-2-cy an oethyl-N,N- 
diisopropylphosphoramidityl-P-D-ribofuranosyl)-4-iodopyrazole (4a)
Procedure D: l-(2'-Deoxy-5'-dimethoxytrityl-p-D-ribofuranosyl)-4-iodopyrazole
(3a) (0.39 g, 0.638 mmol) was twice co-evaporated with pyridine then dissolved in
CH2CI2 (5 mL) and triethylamine (0.4 mL) under Ar. Next,
diisopropylchlorocyanoethylphosphoramidite (150 pL, 0.67 mmol) was added
slowly and the solution was stirred for 1 h. The crude reaction was quenched with
methanol and then washed with brine, dried with Na2SC>4 and concentrated under
reduced pressure. Purification by flash chromatography (2:1:0.05 hexanes-EtOAc-
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Et3N) provided a white foam (0.366 g, 71%). TLC: Rf=0.35 (4:3:1 hexanes-EtOAc-
Et3N); HR FAB (MNBA) Theoretical: 813.2278 (M +H f, Found: 813.2262
(M+H)+; 3lP (101.2 MHz, CDC13) mixture o f diastereomers 5 147.62, 147.35. lH
m ixture o f diastereomers; !H (250 MHz, CDC13) 6  8.23 (s, 1H, H5), 7.68 (s, 1H,
H3), 7.42-7.39 (m, 2H, Ar), 7.31-7.19 (m, 7H, A r), 6.82-6.78 (m, 4H, Ar), 6.05
(app. t, Jh2- 5 .9 , 1H, H I'), 4.69-4.63 (m, 1H, H4r), 4.20-4.16 (m, 1H, H3'), 3.78 (s,
6 H, OM e), 3.66-3.48 (m, 4H, CH3-CH  and O C H 2), 3.24-3.21 (m , 2H, H5’), 2.78-
2.40 (m, 4H, C2 and CH 2-CN), 1.99 (s, 3H, CH3) ,1.32-1.12 (m, 12H, CH3-CH).
2.4.5 l-(2 ’-Deoxy-3,,5,-bis-0-p-toIuoyl-P-D-ribofuranosyl)-4-nitropyrazole 
(lb )
Prepared using procedure A with 4-nitropyrazole (2.77 g, 24.3 mmol), acetonitrile 
(20 mL), NaH (0.62 g, 25.8 mmol) in dry acetonitrile (10 mL), 3, 5-bis-O-p- 
toluoyl-p-D-2-deoxyribofuranosyl chloride (11.94 g, 30.7 mmol), purified by silica 
column (CHC13) to yield 12.24 g (8 6 %) o f a white solid. m.p. 157-158 °C; TLC: 
Rr=0.50 (2:1 hexanes-EtOAc); HR FAB (MNBA) Theoretical: 466.1614 (M+H)+, 
Found: 466.1606 (M+H)+; lH  (200 MHz, CDC13) 8  8.36 (s, 1H, H-5), 8.06 (s,lH , H- 
3), 7.94 (d, Jat=8.2, 2H, A t), 7.88 (d, Jat=8.3, 2H, A t), 7.27 (d, Jat=8.1, 2H, Ar), 
7.22 (d, JAr=8.3, 2H, Ar), 6.20 (app.t, Jh2-=6.0, 1H, H I’), 5.77 (app. dt, Jht=3.2, 
Jh4-=6-3, 1H, H3’), 4.70-4.63 (m, 2H, H4’ & H5’), 4.54 (dd, JH4-=6-2, JH5-=13.5, 1H, 
H5”), 3.22 (app. dt, J=6.2, Jh2-=14.2, 1H, H2'), 2.85 (ddd, JH3-=4 0, JHi-=6.4, 
Jh2^14.4, 1H, H2"), 2.44, 2.41 (s, 3H, CH3-Ar); ,3C (50 MHz, CDC13) 166.10, 
165.80 (C(O)-Ar), 144.48,144.11 (C (0)-A r), 136.22 (C5), 129.65, 129.56, 129.16, 
129.06, (Ar), 127.86, (C3), 126.58, 126.33 (Ar-CH3), 105.00 (C4), 90.66 (Cl*), 
83.60 (C41), 74.56 (C3'), 63.61 (C5’), 37.80 (C2'), 21.60,21.55 (Ar-CH3)
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2.4.6 l-(2'-Deoxy-P-D-ribofuranosyI)-4-nitropyrazoIe (2b)
Prepared using procedure B with l-(2'-deoxy-3',5'-bis-0-p-toIuoyl-P-D- 
ribofuranosyl)-4-nitropyrazoIe (lb ) (1.65 g, 3.54 mmol), ammonia saturated 
methanol (100 mL), purified by column chromatography with silica (4:5 CH2CI2- 
EtOAc) to give a  yellowish oil (0.717 g, 8 8 %). TLC: Rf=0.17 (1:2 CH2Cl2-EtOAc); 
UV-Vis: e260 =5818 M^cm*1; HR FAB (MNBA) Theoretical: 230.0776 (M+H)+, 
Found: 230.0756 (M+H)+; lH  NMR (200 MHz, CD3OD) 6  8.76 (s, 1H, H5), 8 .12 (s, 
1H, H I), 6.14 (app. t, Jh2-=6 4, 1H, 4.50 (app. dd, Jh2-=5 5, JH4-=10 .5 ,1H , H31),
4.02 (app. dd, Jhs-4 .3 , JH3-=8.7, 1H, H4'), 3.75 (dd, JH4-=3 .7 , Jh5-=1 1.9, 1H, H5"), 
3.64 (dd, JH4-=5.17, JH5-=12.0, 1H, H5’), 2.84-2.71 (m, 1H, H2*), 2.52 (ddd, Jh3-=17, 
J h i-=7.1, Jht=13.9, 1H, H2’); ,3C (250 NMR, CD3OD) 5 137.01 (C5), 130.01 (C3), 
92.15 (C l'), 89.70 (C4'), 72.17 (C3’), 63.35 (C5*), 41.44 (C2’)-
2.4.7 l-(2 ,-Deoxy-5,-dimethoxytrityl-(3-D-ribofuranosyl)-4-nitropyrazole (3b) 
Prepare using procedure C w ith l-(2'-deoxy-p-D-ribofuranosyl)-4-nitropyrazole 
(2b) (0.717 g, 3.13 mmol) dry pyridine (15 mL), DIEA (10 mL), DMT-C1 (1.08 g, 
3.18 mmol) and DMAP (0.38 g, 3.11 mmol), purified by column chromatography 
with silica (20:1 EtOAc-CH3OH) to give 1.47 g (8 8 %) o f  oil. TLC: Rf = 0.18 (4:3:1
hexanes-EtOAc-Et3N); FAB MS (NBA) Theoretical 531.5 (M)+, Found 531.4 (M)+;
'H  (250 MHz, CD3OD) 6  8.60 (s, 1H, H5), 8.03 (s, 1H, H3), 7.38-7.35 (dd, J=7, 2H, 
Ar), 7.27-7.11 (m, 7H, Ar), 6.77-6.73 (d, J=8.5,4H , Ar), 6.12-6.08 ( dd, J=4, J=2.3 
1H, H I'), 6.12-6.08 (dd, J=5.01H, H3’), 4.58-4.56 (dd, 1H, H4’), 3.69 (s, 6 H, OMe), 
4.13-4.03 (m, 2H, H5' & H5"), 2.82-2.77 (m, 1H, H2'), 2.46-2.36 (m, 1H, H2"); 13C 
(300 MHz, CD3.OD) 8  160.12 (Ar-OM e), 146.38 (C5), 137.25,137.17 (Ar-C),
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136.96 (C3), 131.35,129.99,129.38, 128.83,127.87 (Ar), 114.15 (C4), 91.98 (C l’), 
88.35 (C4‘), 87.62 (C-Ar), 72.43 (C3’), 65.21 (C5r), 55.79 (OMe), 40.91 (C2f).
2.4.8 l-(2'-Deoxy-5,-dimethoxytrftyl-3,-0-2-cyaiioethyl-N,N- 
diisopropylphosphoramidftyl-P-D-ribofuranosyI)-4-nitropyrazole(4b)
Prepared using procedure D with l-^'-deoxy-S'-dimethoxytrityl-P-D-ribofuranosyl)-
4-nitropyrazole (3b) (0.52 g, 0.9787 mmol), CH2CI2 (5 mL), triethylamine (0.75
mL), diisopropylchlorocyanoethylphosphoramidite (0.3 mL, 1.34 mmol) and
purified by column chromatography with silica (2:1:0.05 hexanes~EtOAc-Et3N) to
give a white foam (0.622 g, 87%). TLC: Rf =  0.70 (4:3:1 hexanes-EtOAc-Et3N);
HR FAB (MNBA) Theoretical: 732.3161 (M+H)+, Found: 732.3153 (M+H)+; 3lP
mixture o f diastereomers (101.2 MHz, CDC13) 5 147.81,147.63. 'H  mixture o f
diastereomers (250 MHz, CDCI3) 8  8.37, 8.35 (s, 1H, H5), 8.04 (s, 1H, H3), 7.39-
7.36 (m, 2H, Ar), 7.29-7.20 (m, 7H, Ar), 6.82-6.78 (m, 4H, Ar), 6.08 (dd, Jh2-=5 .8 ,
Jh2-=8 .7 , 1H, H I’), 4.68 (m, 1H, H4’), 4.28 (app. t, J= 4 .2 ,1H, H3’), 3.78 (s, 6 H,
OMe), 3.70-3.52 (m, 4H, CH3-CH and 0-C H 2), 3.26 (dd, J=7.4, J=14.3, 2H, H5'and
H5"), 2.84-2.56 (m, 4H, C2 and C H a-CN), 1.26-1.08 (m, 12H, CH3-CH).
2.4.9 l-(2'-Deoxy-3',5,-bis-0-p-toluoyl-P-l>-ribofuranosyl)-4-propynylpyrazole
(lc )
l-(2'-Deoxy-3',5'-bis-(9-/?-toluoyl-P-D-ribofuranosyl)-4-iodopyrazole (lb ) (0.545 g, 
0.998 mmol) was dissolved in DMF (5 mL) and triethylamine (1 mL, 7.5 mmol) 
into a 90 mL pressure vessel. The solution was purged with A r and cooled to -78 
°C. 2 mL o f propyne (33 mmol) was condensed into the vessel followed by 
addition o f Cul (0.053 g, 2.63 mmol) and Pd(PPh3)2Cl2 (0.072 g, 0.103 mmol). The 
flask was sealed and warmed to room  temperature with stirring for 24 hours. The
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solvents were removed under reduced pressure and the crude product was purified 
using flash chromatography with silica (CHCI3) to give 0.400 g (0.873mmol) o f  a 
white solid (87%). m .p. 110-112 °C; TLC: R fO .22 (3:1 ether-hexanes); HR FAB 
(MNBA) Theoretical 459.1920 (M+H)+, Found 459.1920 (M+H)+; *H (250 MHz, 
CDCI3) 8  7.93 (d, Jat=7.9, 4H, A t), 7.65 (s, 1H, H5), 7.57 (s, 1H, H3), 7.27 (d, 
Jat=2.4, 2H, A t), 7.21 (d, Jat=7.7, 2H, Ar), 6.16 (t, J h2-=6.1, 1H, H I’), 5.76 (app. dd, 
Jht=3.2, JH4-=6 .4 ,1 H , H3'), 4.60-4.48 (m, 3H, H4* and HS’), 3J21-3.11 (m, IH , H2'), 
2 .6 6  (ddd, JHi=6.6, J h3=3.7 , J h2= 14 .4 , 1H, H2’), 2.42 (s, 3H, A r-CH3), 2.40 (s, 3H, 
Ar-CH3), 1.99 (s, 3H, C-CH3); l3C (50 MHz, CDC13) 8  166.25 (C(O)), 165.87 
(C (0)), 144.26 (C(O)-Ar), 143.78 (C (0)-A r), 142.75 (C5), 131.10 (C3), 129.78 
(Ar), 129.22 (Ar), 129.12 (Ar), 129.02 (Ar), 126.98 (Ar-CH3), 126.67 (Ar-CH3), 
104.83 (C4), 89.78 (C l’), 86.52 (Pyrazole-C), 82.74 (C4’), 75.21 (C31), 70.24 (C- 
CH3), 64.21 (C5’)» 37.35 (C2’), 21.69 (Ar-CH3), 4.27 (C-CH3); Anal, calc’d for 
C27H26N2O5: C 70.73, H 5.72, N 6.11, Found: C 70.56, H 5.71, N 5.92
2.4.10 l-(2'-Deoxy-[}-I>-ribofuranosyl)-4-propynylpyrazole (2c)
Prepared using procedure B with l-(2'-deoxy-3,,5'-bis-0-p-toluoyl-P-D- 
ribofuranosyl)-4-propynylpyrazole (lc ) (1.0 g, 2.18 mmol), ammonia saturated 
m ethanol (100 mL) and purified using flash chromatography (1 :2 CH2Cl2-EtOAc) to 
give a yeUowish oil.(0.41 g, 85%). TLC: Rf=0.24 (9:1 CHCI3-CH3OH); UV-Vis:
£260 =127 M '1cm l; HR FAB (MNBA) Theoretical 223.1083 (M+H)+, Found 
223.1082 (M+H)+; ‘H (250 MHz, CDCI3) 8  7.60 (s, 1H, H5), 7.56 (s, 1H, H3), 6.00 
(t, J h2= 6 .2 , 1H, H I’), 5.09 (app. d, J=5.4,1H , H3*), 4.04 (app. d, J=2.3, 1H, H4'), 
3.81-3.77 (m, 1H, H5’), 3.69-3.61 (m, 1H, H5’), 2.74-2.63 (m, 1H, H2’), 2.32 (ddd,
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J=1.5, J=5.8, J=13.0,1H , H2’), 1.96 (s, 3H, CH3); l3C (62.5 MHz, CDCI3) 5 143.00 
(C5), 131.68 (C3), 104.04 (C4), 89.79 (C l1), 88.87 (C4*), 86.69 (pyrazole-C), 72.44 
(C3’>, 69.76 (C-CH3), 63.25 (C51), 41.50 (C2’), 4.15 (C-CH3); Anal. C alc’d for 
C n H,4N20 3 : C 59.45, H 6.35, N  12.61, Found: C 59.27, H  6.34, N 12.36.
2.4.11 l~(2'-Deoxy-5'-dimethoxytrityl-P-D-ribofuranosy[)-4-propynylpyrazole
(3c)
Prepared using procedure C w ith 1 -(2'-deoxy- P-D-ribofurano syl)-4- 
propynylpyrazole (2c)(0.41 g, 1.845 mmol), DMT-C1 (0.938 g, 2.77 mmol) and 
DMAP (0.338 g, 2.76 mmol) and purified using flash chromatography (4:3:1 
hexanes-EtOAc-Et3N) to give 0.757 g (83%) o f oil. TLC: Rr=0.54 (4:3:1 hexanes- 
EtOAc-Et3N); FABMS (glycerol) Theoretical 525.6 (M+H)+, Found 525.5(M+H)+; 
'H  (200 MHz, CDCI3) 5 7.54 (s, 1H, H5), 7.41 (s, 1H, H3), 7.34-7.31 (m , 2H, 
DMT), 7.23-7.07 (m, 7H, DM T), 6.75-6.69 (m, 4H, DMT), 5.93 (dd, Jh2«=4.6, 
Jh2-=6 -6 , 1H, H 10,4.50 (dd, J=5.8, J=10.9, 1H, H3'), 3.92 (dd, J=5.1, J=10.1,1H , 
H4'), 3.71 (s, 6H, OCH3), 3.27-3.09 (m, 2H, H5'), 2.73-2.61 (m, 2H, H 2'), 1.91 (s, 
3H, CH3); I3C (50 MHz, CDC13) 8  158.48 (Ar-OCH3), 149.10,144.67 (DMT), 
142.24 (C5), 135.84 (C3), 130.73,130.02, 128.13, 127.82, 126.76,113.14 (DMT), 
104.39 (C4), 89.24 (C l'), 86.40 (C-(At)3), 85.63 (Pyrazole-C), 85.63 (C4'), 72.37 
(C3'), 70.42 (C-CH3), 64.06 (C5'), 55.15 (OCH3), 39.73 (C2), 4.21 (C-CH 3); Anal. 
Calc’d for C32H32N20s*H20: C 70.83, H 6.32, N 5.16, Found: C 69.95, H6.08, 
N5.12.
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2.4.12 1 -{2 '-Deoxy-5 '-dimethoxytrity 1-3 '-tf-2-cyanoethy l-N,N- 
diisopropyIphosphorainidityl-P-D-ribofunuiosyI)-4-propynylpyrazole 
(4c)
Prepared using procedure D with l-(2'-deoxy-5'-dimethoxytrityl-P-D-ribofuranosyI)- 
4-propynylpyrazole (3c) (1.093 g, 2.22 mmol),
diisopropylchlorocyanoethylphosphoramidite (0.3 mL, 1.34 mmol), purified using 
column chromatography with silica (2:1:0.05 hexanes-EtOAc-Et3N) to give a white 
foam (1.313 g, 89%). TLC: R<= 0.56 (4:3:1 hexanes-EtOAc-Et3N); HR FAB 
(MNBA) Theoretical: 725.3479 (M+H)+, Found: 725.3427 (M+H)+; 3lP (101.2 
MHz, CDCI3) mixture o f diasteromers 8  155.28, 155.01; *H mixture o f 
diastereomers (250 MHz, CDC13) 8  7.67 (s, 1H, H5), 7.50 (s, 1H, H3), 7.43-7.40 (m, 
2H, Ar), 7.31-7.19 (m, 7H, Ar), 6.82-6.78 (m, 4H, Ar), 6.05 (app. t, Jh2-=5.9, 1H, 
H I'), 4.69-4.63 (m, 1H, H4'), 4.20-4.16 (m, 1H, H3’), 3.78 (s, 6H, OCH3), 3.66-3.48 
(m, 4H, CH3-CH and Q-CH2), 3.24-3.21 (m, 2H, H5'), 2.78-2.40 (m, 4H, C2  and 
CH 2-CN), 1.99 (s, 3H, CH3),1.32-1.12 (m, 12H, CH3-CH).
2.4.13 l-(p - D -2'-Deoxyrlbofuranosyl)-3',5'-bis-0-(p-toluoyl)-4- 
trimethylstannyl-pyrazole (Id)
To a solution o f l-(P-D-2'-deoxyribofuranosyl)-4-iodo-pyrazole (la) ( 3.21 g, 5.88
mmol) and toluene (70 mL) under N2 was added hexamethyldistannane (2.7 mL,
13.0 mmol) followed by rapid addition o f Pd(PPh3)4(60 mg, 5.19 pmol). The
reaction mixture was stirred and heated to 90 °C for 3 h and then concentrated under
reduced pressure. The crude product was purified by flash chromatography (8:2:1
hexanes-EtOAc-Et3N) providing a clear oil (2.90 g, 8 6 %). TLC: R /0.42 (4:1,
hexanes-EtOAc); HR FAB (MNBA) Theoretical 585.1411(M+H)+, Found 585.1385
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(M+H)+; !H (200 MHz, CDCI3) 8  8.06 (d, 4H, Ar,), 7.68 (s, 2H, pyrH), 5 7.29 (dd,
J= 8.0 Hz, 4H, Ar,), 6.4 (t, J=7.9 Hz, 1H, H I'), 5.90 (br s, 1H, H3'), 4.60-4.74 (m,
3H, H47H5'), 3.31 (dt, J h t-1 3 .7  H z, ./=  6.7 H z, 1H, H 2'), 2.76 (ddd, 13.7, J =
6 .1, 3.1 Hz, 1H, H 2'), 2.47 (s,3H, Ar-CH3), 2.45 (s, 3H, Ar-CH3), 0.32 (s, 9H
(CH3)3-Sn; ll7Sn/ ,19Sn sateUites, 2d, J=  56,46 Hz); l3C (50 MHz, CDC13) 8  165.97
(A r-C (0)), 165.65 (A r-C (0)), 145.91 (C5; u 7Sn/ 119 Sn satellite, 2d^=  approx. 443
Hz), 143.92 ((A r-C(0)), 143.48 (A r-C (0)), 133.15 ( C3; u7Sn/ ll9Sn satellite, 2d,
J= approx. 66  Hz), 128.59 (Ar), 129.52 (Ar), 129.30 (Ar), 128.96 (Ar), 126.83 (A r-
CH3), 126.57 (Ar-CH3). 111.84 ( C4; U7Sn ll9Sn satellite, 2d, J= approx. 443 Hz),
89.27 (C l'), 82.33 (C3'), 75.27 (C4'), 64.21 (C5'), 37.37 (C2'), 21.43 (Ar-CH3), -
9.43 ((CH3)3-Sn); (ll7Sn/U9Sn satellites, 2d, J=Z52, 371 Hz); Anal, calc’d for
C27H32N20 5 Sn: C, 55.47.; H, 5.52; N, 4.79; Found C, 55.60: H, 5.33: N, 4.78.
2.4.14 1-(P~D -2'-DeoxyribofuranosyI)-3 ,5 '-bis-0-(p-toluoyl)-4-(2-thiazolyl)- 
pyrazole (le )
To a solution o f l-(P-D-2'-deoxyribofuranosyl)-4-trimethylstannyl-pyrazole (Id ) 
(2.90 g, 4.97 mmol) in DMF (62 mL) under N2 was added 2-bromothiazole (2.77 
mL, 30.4 mmol) followed by rapid addition o f Pd(PPh3)4 (0.055 g, 47.5 pmol). The 
reaction mixture was stirred and heated to 90 °C for 20 h and then concentrated 
under reduced pressure. The crude product was purified by flash chromatography 
(2:1 hexanes-EtOAc) providing a white solid (1.49 g, 60%).TLC: R/0.38 (2:1 
hexanes-EtOAc); m.p. 134-136 °C; HR FAB (MNBA) Theoretical 504.1595 
(M+H)+, Found 504.1624 (M + H f; *H (200 MHz CDCI3) 8  8.10 (s, 1H, thiazole 
H4), 7.90-7.97 (m, 5H, Ar, thiazole H5), 7.75 (d, J=3.5 Hz, IH, H5), 8  7.16-7.28
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(m, 5H, Ar, H3), 6.25 ppm  (t, J=6.2 Hz, 1H, H I'), 5.82 (dt, > 6 .2 ,3 .1  Hz, 1H, H3'), 
4.49-4.68 (m, 3H, H 4'/H 5'), 3.19 (dt, Jm -1 3 .8 , J=  6.7 Hz, 1H, H 2'), 2.73 (ddd, J m  
=  13.8, J=  7.1, 3.5 Hz, 1H, H 2'), 2.43 (s, 3H, Ar-CH3), 2.38 (s, 3H , Ar-CH3); ,3C 
(50MHz, CDC13) 8  165.62 (A r-C (0)), 165.25, (A r-C (0», 159.52 (thiazole C2),
143.16 ( pyrazole C5), 143.68 (A r-C (0» , 142.39 (A r-C (0)), 138.08 (pyrazole C3),
129.17 (Ar), 128.61 (Ar), 128.46 (Ar), 126.7 (thiazolyl C5), 126.33 (Ar-CH3),
126.07 (At-CH3), 117.84 (pyrazole C4), 116.5 (thiazolyl C4), 89.47 (C l'), 82.41 
(C3'), 74.56 (C4'), 63.52 (C5'), 37.01 (C2'), 21.07 (Ar-CH3), 21.00 (Ar-CH3);
Anal, calc’d for C27H25N30 5S: C, 64.40; H, 5.00; N, 8.31; found C, 64.27: H, 5.33: 
N, 8.31
2.4.15 l-(f$-D -2'-DeoxyribofuranosyI)-4-(2-thiazolyl)-pyrazole (2e)
Prepare using procedure B withl-({i-D-2'-deoxyribo£uranosyl)-3 ',5  -bis-0-{p- 
toluoyl)-4-(2-thiazolyl)-pyrazole (le ) (1.26 g, 2.43), ammonia saturated methanol 
(120 mL) and purified using flash chromatography (30:1 CHCl3-CH3OH) yielded a 
white solid (0.50 g, 76%). TLC: R /0.16 (CHC13); UV-Vis: e26o=6,927 NT‘cm 1; m.p. 
89-91 °C; HR FAB (glycerol) Theoretical 268.0746 (M+H)+, Found 268.0759 
(M+H)+; ‘H (250MHz, CDC13) 8  8.10 (s, 1H, thiazolyl H4), 7.95 (s, 1H, thiazolyl 
H5), 7.72 (d, >=3.3 Hz, 1H, H5), 7.21 (d, J=2.85,1H, H3), 6.17 (t, J=6.2 Hz, 1H, 
H I'), 4.91 (br s, 1H, OH3'), 4.74 (s, 1H, H 3'), 4.26 (br s, 1H, OH5'), 4.16 (s, 1H, 
H 5'), 3.80 (dd, > 1 2 .2 ,1 1.7, 2H, H 4') 2.83 (dt, /h 2 = 1 3 .1 , J=  6.4 Hz, 1H, H2'), 2.45 
(ddd, Jm = 13.6, J=  6.5, 3.4 Hz, 1H, H2'); 13C (50MHz, CDC13) 8  159.52 (thiazole 
C2), 142.3 ( pyrazole C5), 138.08 (pyrazole C3), 127.5 (thiazolyl C5), 117.0
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(pyrazole C4), 116.9 (thiazolyl C4), 89.7 (C l'), 88.4 (C3'), 71.7 (C4'), 62.7 (C5'),
41.0 (C2’); Anal, calc’d for C, lH ,4N 30 3 S: C, 49.43; H, 4.91; N, 15.73; Found C, 
49.32: H, 5.11; N, 15.53.
2.4.16 (3e) l-[5'-0-(D im etlioxytrityI -P-D -2'-deoxyribofuranosyl)]-4-(2- 
thiazolyl)-pyrazole
Prepared using procedure C with 1-(P-D -2'-deoxyribofuranosyl)-4-(2-thiazolyl)- 
pyrazole (2e) (0.409 g, 1.53 mmol) , pyridine (10 mL), DMAP (0.28 g 2.29 mmol), 
DIEA (3 mL) and DMT-C1 (0.789 g 2.32 mmol). Purification o f  the crude product 
by flash chromatography (200:2:1 CHCl3-CH3OH-Et3N) yielded a yellowish solid 
(0.400 g, 46%). TLC: R/0.33 (9:1 CHCh/CT^OH); m.p. 63-65 °C; HR FAB 
(MNBA) Theoretical 570.2062 (M + H )\ Found 570.2064 (M+H)+; lH (300MHz 
CDC13) 6  8.07 (s, 1H, thiazolyl H4), 7.91 (s, 1H, thiazolyl H5), 7.73 (s, 1H, H5), 
7.41-7.17 (m. 9H, Ar-OCH3, Ar-OGH3, H3), 6.78 (d, 5H, Ar), 6.11 (dd, JH a^-2,
4.6 Hz, 1H, H I'), 4.65 (app. dd, J h ^ I O .5  Hz, Jh i^ IO .5  H z, Jm-=6.0 H z,lH , H3'),
4.05 (app. dd, ^ 3-= 10.5 Hz, Jhs^IO .5 Hz, J h s ^ .I  Hz,1H, H4'), 3.36 (app. dd, 
Jh ^ IO .5  Hz, Jh5'=10.5 Hz, JH5=5.5 Hz,1H, H5'), 3.25 (app. dd, Jhs^IO .5 Hz, 
Jh ^ IO .5  Hz, Jh2'=5.1 Hz,1H, H5”), 3.76(s, 6H, At-OCH3, Ar-OCH3) 2.85 (ddd 
Jh2^ 12.3 Hz, Jh3'= 10 .5  Hz, JHr=  6.4 Hz, 1H, H2'); ,3C (75MHz, CDC13) 5 158.8 ( 
pyrazole C5), 145.0 (thiazolyl C2), 138.6 (pyrazole C3), 127.5 (thiazolyl C4), 136.2 
(pyrazole C4), 130.4, 128.5, 128.2, 127.5, 127.2 (DMT), 117.5 (thiazolyl C5),
113.5 (DMT), 89.95 (C l') , 86.8  DM T, 86.1 (C3'), 72.9 (C4'), 64.4 (C5'), 
55.5(DMT), 40.3 (C2'); Anal, calc’d for C32H3iN30 5S: C, 67.46; H, 5.49; N, 7.38; 
Found C,67.28; H,5.29 ; N, 7.35.
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2.4.17 l-(2'-Deoxy-5'-dimethoxytrityl>3,>0~2-cyanoetIiyl>NyN-
diisopropylphosphoramidityl-P-D-ribofuraiiosyI)-4-(2-thiazolyI)- 
pyrazole (4e)
Prepared using procedure D with 1 -(2'-deoxy-5’-dimethoxytrityl-P- D -  
ribofuranosyl)-4-(2-thiazolyl)-pyrazole (3e) (150 mg, 195 pmol), CH2CI2 (2 mL), 
triethylamine (1.5 mL), diisopropylchlorocyanoethylphosphoramidite (100 pL, 0.44 
mmol). Purification by flash chromatography (2:1:1 hexanes/EtOAc/Et3N) 
provided a yellowish oil (55 mg, 25%). TLC: R /0 .25 ,0.18 (2:1 hexanes-EtOAc); 
HR FAB (MNBA) Theoretical 770.3140 (M+H)+, Found 770.3182 (M+H)+; 3lP 
(101.2 MHz) 8  147.7, 147.4 mixture o f 2 diastereomers; lH NMR (300MHz C<>D6) 
5 8.05 (m, 1H, thiazole H4), 7.90 (m, 1H, thiazolyl H5), 7.65 (m , 2H, H3, H5), 
7.56-7.47 (m. 6H, Ar), 7.04-6.99 (m, 2H, Ar), 6.75-6.72 (m, 4H, Ar), 6.51 (m. 1H, 
H I'), 5.78 (m, 1H, H3'), 4.92 (m, 1H, H4'), 4.43 (m , 2H, H 5'), 3.51-3.4 (m, 4H, 
CH3-CH and O-CH2,). 3.31 (m, 6H, Ar-OCH3), 3.27-3.19 (m, 4H,), 2.98-2.86 (m, 
1H, H2').2.41-2.19 (m, 1H, H2'), 1.79-1.61 (m) ,1.36-1.24 (m), 1.14-1.01 (m), 1.01- 
0.9(m) mixture o f 2 diastereomer.
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Chapter 3
Thermodynamic Stability of Oligonucleotides containing Pyrazole
Nucleobase Analogs
3.1 Structure o f DNA
Figure 3.1 Structure of 5'-TCGA-3' nucleotide
DNA is a polymer o f nucleotides connected from the 3 ' end o f  one base to
two antiparallel DNA strands. The bases o f one strand hydrogen bond with the 
bases on the opposite strand in the center o f the helix. The bases are planar with the 
helical axis perpendicular to the base planes. The bases form hydrogen bonds 
across the plane specifically between purines and pyrimidines. Hydrogen bonds 
form “exclusively” between A and T and between G  and C (Figure 3.2). Any other 
pairing between the two strands is considered a mismatch. Another interaction
o
OH
the 5' end o f  the next base (Figure 3.1). In nature DNA structure can be found as a 
double helix as discovered by Watson and Crick 1. The double helix is comprised of
40
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between the bases is called base stacking. Base stacking occurs between bases 
perpendicular to the helix axis.(See Section 2.1) The aromatic systems o f  the bases 
offer n  rich clouds as well as charge variation due to the positive and negative 
centers from the nitrogens and oxygens in the bases. (See Figure 2.2)
Figure 3.3. Structures of 4-substituted pyrazole nucleoside analogs 
3.2 DNA Thermal Denaturation and Thermodynamic Analysis 
3.2.1 Sequences Investigated
Two series o f sequences were investigated. The first set o f  sequences were 
designed based on the self-complementary Dickerson sequence. The Dickerson 
sequence is a well known and studied sequences with many published NMR and 
crystal structures.
H
CH, o - - H —N u
H
N-H—O N
R O R O --H -N
H
T A C G
Figure 3.2 Hydrogen bond pairs between purines and pyrimidines
HO HO HO HO
Pzl PzN PzP PzT
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Table 3.1 Sequences for self-complementary sequences
X-A 5’ CGC QAA TTA GCG 3’
X-C 5’ CGC QAA TTC GCG 3’
X-G 5’ CGC QAA TTG GCG 3’
X-T 5’ CGC QAA TTT GCG 3’
Table 3.2 Sequences for non-self-complementary sequences
Sequence 1 5'CAA AQT GGT GGC CAA GT 3’ 
3’GTT TTA CCA CCG GTT CA 5’
Sequence 2 5’ CAA AAT GGQ GGC CAA GT 3’ 
3' GTT TTA CCA CCG GTT CA 5'
Sequence 3 5’ CAA AAQ GGQ GGC QAA GT 3’ 
3* GTT TTA CCA CCG GTT CA 5’
Sequence 4 5’ CAA QQT GGT GGC CQA GT 3’ 
3' GTT TTA CCA CCG GTT CA 5'
3.2.2 Thermal Denaturation
Thermal denaturation o f a DNA duplex is when the duplex is converted to 
two individual strands with heat. The point at which half o f  the helix is unwound 
our half o f  the duplex is in single stranded state is called the melting temperature or 
Tm. The Tm can be measured in several different ways. The method most often 
used is temperature-dependence UV absorbance spectroscopy and the second
method is differential scanning calorimetry (DSC).^ DSC monitors the change in
42
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heat capacity while changing the temperature. The first method monitors the 
change in UV absorbance while changing the temperature. Each method analyzes 
the shape o f  or the area under the curve to provide the initial thermodynamic data.
3.2.3 Analysis o f Data from Thermal Denaturation Studies
UV melting was performed as previously described.^ The melting 
temperature, Tm, is defined as the point at which a  = 0.5, where a  is defined as the 
mole fraction o f single stranded DNA in the duplex state. It is assumed melting 
behavior is two state and there are no intermediates. In a non two-state transition, 
the melting curve will not have the characteristic shapeindicative o f two state 
transtions. The equilibrium constant, at Tm, is given by the following,
K  = -------C——-t—  for self-complementary sequences and K  = ---- —  for non-
2(1 — a ) Ct {\ — a ) Ct
self complementary sequences. Analysis o f melting data was performed with the
program, Meltwin©, a non-linear least squares fitting program which determines Tm
and thermodynamic data from single melting curves. For each sequence a series of
melts were performed over at least 100-fold concentration range. To determine the
thermodynamic parameters, AHvh and ASvh> van’t Hoff style analysis was
performed according to the following equations:
The free energy, AG o f  the system was calculated at 298K using Gibb’s equation: 
AG = A H -T A S .
for self-complementary sequences
Tn,
+  for non-self complementary sequences
AH
43
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3.3 Results
3.3.1 Self-Complementary Sequences
Table 3.3 Thermodynamic data for self-complementary sequences
X-Y Tm°C 
(15 p M )
ATm 
per mod. °C
A H
(kcal/mol)
AS
(cal/K»mol)
A G  
(kcal/mol at 
298 K)
Con T-A 55.8 -69.5 -189.3 -13.1
Con G-C 67.0 -87.7 -235.9 -17.4
Con C-G 62.2 -69.1 -183.9 -14.3
Con A-T 61.9 -80.9 -219.3 -15.5
Ind-A 26.3 -14.8 -28.5 -73.1 -6.7
Ind -C 32.0 -17.5 -20.4 -44.8 -7.1
In d -G 34.1 -14.1 -32.9 -84.9 -7.6
In d -T 38.4 -11.7 -30.3 -75.3 -7.9
Pzl-A 22.5 -16.7 -39.0 -110.0 -6.3
Pzl-C 4.7 -31.1 -28.8 -81.7 -4.5
Pzl-G 9.5 -26.3 -26.8 -72.8 -5.1
P z l-T 13.7 -24.1 -26.5 -70.4 -5.5
PzN-A 27.2 -14.3 -31.9 -84.3 -6.8
PzN-C 20.0 -23.5 -28.9 -76.6 -6.1
PzN-G 18.6 -21.8 -41.6 -120.4 -5.7
PzN-T 19.4 -21.2 -31.6 -85.8 -6.0
PzP-A 26.3 -14.7 -35.8 -97.6 -6.8
Table 3.3 continued
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X-Y Tm C 
(15 pM )
ATm 
per mod. °C
AH
(kcal/mol)
AS
(cal/K*mol)
AG 
(kcal/mol at 
298 K)
PzP-C 15.4 -25.8 -41.3 -121.2 -5.2
PzP-G 26.0 -18.1 -43.0 -121.8 -6.7
PzP-T 15.7 -23.1 -25.3 -65.6 -5.8
PzT-A 33.4 -11.2 -47.6 -133.2 -7.9
PzT-C 24.0 -21.5 -32.7 -88.0 -6.5
PzT-G 36.2 -13.0 -42.9 -116.7 -8.2
PzT-T 27.9 -17.0 -33.8 -90.3 -6.9
3.3.2 Non-Self-Complementary Sequences
Table 3.4 Melting temperature (Tm) and thermodynamic parameters for non­
self-complementary duplexes
Nucleoside-
Sequence
Tm C 
(15 pM )
ATm 
per mod. 
°C
A H
(kcal/mol)
AS
(cal/K*mol)
A G 
(kcal/mol at 
298 K)
Control 72.2 -172.5 -475.0 -31.0
Ind-1 71.6 -0.6 -106.4 -283.8 -21.8
Ind-2 65.9 -6.3 -125.2 -344.5 -22.5
Ind-3 48.2 -8.0 -108.9 -314.1 -15.2
Ind-4 51.9 -6.8 -52.4 -136.6 -11.7
PzN-1 66.2 -6.1 -66.1 -170.1 -15.4
PzN-2 64.8 -7.4 -119.0 -327.4 -21.4
PzN-3 41.0 -10.4 -78.2 -224.4 -11.4
Table 3.4 continued
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X-Y Tm AC 
(15 p M )
ATm 
per mod. 
°C
AH
(kcal/mol)
AS
(cal/K*mol)
AG 
(kcal/mol at 
298 K)
PzN-4 58.1 -4.7 -51.1 -129.5 -12.5
PzP-1 65.7 -6.6 -104.0 -282.1 -19.9
PzP-2 65.4 -6.9 -126.2 -348.2 -22.5
PzP-3 41.2 -10.3 -94.9 -277.3 -12.3
PzP-4 56.3 -5.3 -93.8 -259.9 -16.3
PzT-1 69.3 -2.9 -83.3 -218.4 -18.2
PzT-2 64.5 -7.8 -85.7 -229.2 -17.4
PzT-3 45.0 -9.1 -81.7 -232.2 -12.5
PzT-4 59.8 -4.2 -87.5 -238.2 -16.5
3.4 Discussion
3.4.1 Self-Complementary Sequences
We chose these Dickerson-based self-complementary sequences to be 
consistent with the analysis Bergstrom and coworkers have perfo rm ed .^  The
general trend of our data agrees with their work^ (Table 3.4) but our reported Tms o f 
sequences common between the two are generally higher. This is likely due to the 
difference in the methods used to analyze the data. They used the method o f 
Carothers and Gralla^ whereby T \a and T3/4 are used to determine AH from a single 
curve. In contrast, we have used the program Meltwin© which fits a  throughout 
the curve via a Marquardt-Levenberg non-linear least squares algorithm to 
determine Tm. Additionally, we have used four Dickerson-like control 
s e q u e n c e s 4 > 6 - 8  f o r  purposes o f  comparing a  series o f an analog across from all four
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natural bases. This is particularly important in that the sequences with purines in 
the “Y” position, ConT-A and ConC-G (see Table 3.4), have Tms ~5 degrees lower 
than the sequences in which the purines are in the “X” position (ConAT and ConGC 
resp.). Thus we analyze our data in terms o f  AT„/substitution to take into account 
the different stacking energies already present in the parent sequences. As 
suggested by Freier,^ we feel the ATm analysis is probably more valid than 
comparison o f thermodynamic parameters as the cooperativity o f the melting 
transitions is variable with the different analogs.
The average ATm’s show the pyrazole analogs are much more stable when 
paired with purines than with pyrimidines. This is partly the case with Ind  except 
with T. Possibly a variation in the syn or anti configuration o f  the indole ring could 
explain this phenomena with the lowest ATm with T as its pairing partner. All the 
analogs show decreased stability increase with C as the pairing partner. In spite of 
Con-TA sequence having the lowest Tm o f the four natural controls, each of the 
pyrazole analogs have the highest Tm when paired with A when compared to the 
other three complements. In each self-complementary data set, the pyrazole analog 
that destabilizes the duplex the least is PzT. This is probably due to the increased 
size and increased charge distribution the thiazole ring has over the other pyrazole 
substituents. Froehler has shown the propynyl unit substituted on pyrim idines^ 
and purines^ I raises the Tm by approx. 1.5 °C and 1-1.4 °C per substitution, 
respectively. The average ATm for the propynyl unit was -7°C, perhaps lack of the 
charge distribution or lower polarizability are responsible for the lower 
thermodynamic stability as well as the substituents being placed on a non-hydrogen
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bonding base. Pzl was extremely destabilizing as demonstrated by the very low 
Tm's. Thus, the iodo group provides no added stability over an unsubstitued pyrazole 
wich Bergstrom showed to be equivalent to an abasic site.4 The nitro group is much 
less destabilizing than the iodo group. The smaller size and better charge 
distribution would make it a more suitable substituent. Comparing the Tm values for
PzN to the values reported by Bergstrom,^ the same trends are found with a slight 
variation in the actual numbers. This could be due to the different methods o f 
analysis.
Self-Complementary Sequences
c  3 5 -
Ind Pzl PzN PzP PzT 
Modification (X)
Figure 3.4 Comparison of -ATm for each modification with all the natural bases
The pyrazole analogs overall are not as indiscriminate as Ind, but PzT is 
more stable than Ind when paired with A as well as with G. This may be related to 
the pairing partner size. It appears part o f the reason for the pairing preferences may 
be an attempt at maintaining the traditional size o f the natural pyrimidine-purine 
pair. The pyrazole analogs prefer pairing with A. When the pyrazole analogs are 
paired with A, they are replacing a pyrimidine, comparable in size, in center o f the 
duplex.
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S e lf-C o m p lem en ta ry  S e q u e n c e s
■ Ind 
i|Pzl
■  PzN 
B PzP
■ PzT
■ Avg.
Figure 3.5 Comparison of ATm for each natural base with all of the 
modifications
This maintains the traditional purine-pyrimidine size in the duplex. This may 
also explain the increase in the ATm. When the analogs are paired with C, the 
pyrazole analogs are replacing G in the sequence, offering a "pyrimidine- 
pyrimidine" or mismatch in size in the center o f  the duplex, therefore much more 
destabilizing to the duplex than the natural complement. The pyrazole analogs are 
less destabilizing to the duplex than Kool’s analogs 4,6-dimethyindole and 2,4- 
diflourotoulene. Both o f  these analogs are very non-polar and do not offer the same 
charge variation the pyrazole analogs offer. 4,6-Dimethylindole, which is designed 
as an A analog, does not thermodynamically favor pairing with T and shows the
following preference O  A> G> T.12 2,4-Difluorotoluene was found to favor
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pairing with C while it was designed as a T mimic and shows the following 
thermodynamically favored pairing preferences C > G> A> T.12 As both these 
analog are favoring pairing with C they are “replacing” a G  in the natural sequence
3.4.2 Non-Self Complementary Sequences
P r e v i o u s l y ,  13-15 it has been shown a single modification in the center o f a 
duplex is more destabilizing than a modification near an end. Our data (Table 3.5), 
Sequence 1 vs. Sequence 2 and Sequence 3 vs. Sequence 4, supports this 
observation as well. As expected from the self-complementary data, PzT 
modification appears to be the least destabilizing o f the pyrazole modifications but 
not as stable as Ind. The results from Seq. 4 show that the pyrazole bases are able 
to stack side well side-by-side. Bergstrom has suggested a ring nitrogen and its 
ability to hydrogen bond if  in the correct position makes the base more 
discriminating. The imidazole N3 when paired with G, according to models, is in a 
position capable o f H-bonding similar to a C without disturbance of the duplex,as 
suggested by Bergstrom et al. The ring nitrogen for pyrazole is in the 2 position and 
would require some distortion o f  the duplex to H-bond with G and additionall it is a 
much weaker hydrogen-bond acceptor than an imidazole N-3. The natural bases 
have charge centers in different positions abling them to stack with favorable charge 
interaction with the bases above and below. Some o f the analogs studied although 
7r-rich, lack the charge distribution and are not good stacking bases. The thiazole 
analog provides both positive and negative centers which can improve its ability to 
stack, as well as the Tt-systems o f  the two 5 membered rings, which may explain 
higher Tms o f  PzT containing oligonucleotides.
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Non-Self Complementary Sequences
1 2  -
■ Ind
■  PzN
■  PzP
■  PzT
1 2 3 4
Sequence
Figure 3.6 Comparison o f ATm for non-self-complementary sequences
A possible explanation for the very low -ATm for Ind in Sequence 1 when 
compared to the pyrazole analogs could be due to preferences in pairing partners. 
The self-complementary data shows Ind prefers pairing with pyrimidines over 
purines. The self-complementary data also shows the pyrazole analogs do not favor 
pairing with pyrimidines. Sequence 1 has the modification across from C. As Ind 
favors this pairing and the pyrazole analogs do not this might explain the large 
difference in the -ATm shown in Figure 3.6.
3.5 Summary
Comparison of the data for both each sequences show the pyrazole analogs 
have pairing preference for the natural base A. The analogs are capable of being 
incorporated into a duplex without disrupting the natural order o f the duplex. The 
thiazolyl substituent shows the best ability to stabilize the duplex when compared to
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the other substituents. The pyrazole analogs are not a indiscriminate as Ind when 
pairing with the four natural bases.
3.6 Experimental
3.6.1 UV Thermal Denaturing Measurements.
Absorbance measurments were recorded at 260 nm on a Gilford Response 
UV/VIS Spectrophotomer equipped with a Peltier temperature controlling device 
and thermal software while the temperature was raised from 5 °C to 95 °C in 0.5 °C 
increments under an inert atmosphere. To determine that evaporation was less than 
5%, the average o f  3-5 absorbance readings was determined at 5 °C and/or 25 °C 
before and after each melt. Prior to measurement all samples were heated to 95°C 
for 2 min to drive the equilibrium to single strand. They were then cooled to 5°C 
and equilibrated for 5 min to allow for duplex formation. One concentration for 
each duplex was determined in both a heating and cooling ramp to ensure that the 
duplex behaved the same way. Then 3-8 concentrations (covering at least a 100- 
fold concentration difference) were run in a heating run at 1 °C / min.
3.6.2 Solvent Preparation
An estimate o f  the amount o f  oligonucleotide needed was determined by 
UV(260 nm) (Gilford) in H2O and the sample was evaporated to dryness. The 
DNA duplexes were dissolved in water and had a final buffer concentration o f 1 M 
NaCl, 1 mM EDTA, 10 mM Na2HP0 4 - The cell pathlength varied from 0.01 cm to 
1 cm. All solvents were degassed in a vacuum desiccator prior to use. The 
concentration was determined using the assumption at high temperature the 
oligonucleotides are unstacked and unpaired. The absorbance was determined at 85
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°C and Beer's Law was used to determine the concentration utilizing an estimate of 
the extinction coefficients as calculated below.
3.6.3 Extinction Coefficients fo r Oligonucleotides
The nearest neighbor estimate for each non-modified sequences was determined 
using the method and values from the literature. 16,17 The straight sum o f  the 
extinction o f the mononucleotides in each non-modified sequence was made. The 
ratio o f nearest neighbor values: straight sum method was calculated. The ratio was 
then multiplied by the straight sum o f the individual mononucleotides (incorporating 
the determined extinction coefficients of the modified nucleosides) for the modified 
sequences. This will provide a nearest neighbor estimate for the extinction 
coefficient as the extinction coefficient for each dinucleotide needed for nearest 
neighbor estimates is not known.
3.6.4 Calculation of Thermodynamic Param eters
The Tm as well as AH, AS and AG were determined for each concentration
using Meltwin© provided by Jeffrey McDowell. 18 This program fits a curve to the 
raw data points. The parameters from the curve allow for determination o f  the Tm, 
AH, AS and calculation o f AG for each individual concentration. Once analysis was 
completed for three or more concentrations, van’t Hoff analysis was done to provide 
the thermodynamic values reported. The program provided Tm at a concentration of 
100 pM and AG at 310 K, using the 1/Tm and In Ct/C0 relationship for self and non­
self complementary sequences the Tm’s were converted to be reported at 15 pM and 
AG at 298 K using the relationship o f  AG = A H —TAS and AG = —R T  In K ,
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rearrangement results in the following equation K  = exp^ - ^ - —~ ~ j  , which allows
for van’t H off analysis o f the linear relationship between 1/Tm and In Ct/C0 to be 
used.
3.6.5 DNA Melting Experiments and  Therm odynam ic Analysis
UV melting was performed as previously described. 3 The melting temperature, Tm, 
is defined as the point at which a  =0.5 when a  is defined as the mole fraction o f 
single stranded DNA in the duplex state. It is assumed melting behavior is two state 
and there are no intermediates. The equilibrium constant, at Tm, is given by the
following, K  = — —— ^  for self complementary sequences and K  =
2(1 —a )  C  (1 - a ) 2Cr
for non-self complementary sequences. Analysis o f melting data was performed 
with the program, Meltwin©, a non-linear least squares fitting program which 
determines Tm and thermodynamic data from single melting curves. For each 
sequence a series o f  melts were performed over at least 100-fold concentration 
range. To determine the thermodynamic parameters, A H vh and ASvh, van’t Hoff 
style analysis was performed according to the following equations:
 ^ ^  o^r self 'cornPlementary  sequencesTm I AH
Tm I AH
'C A
Co
4
+ for non-self complementary sequences
The free energy, AG, was calculated from the determined AHvh and ASvh using the 
equation: AG=AH-TAS.
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Table 3.S Self-Complementary Sequence Data for each analysis
Sequence Cone.
HM
AH
kcal/mol
AS 
cal/mol K
AG
kcal/mol
Tm
°C
R  value
Cont TA 3.6 -50.15 -129.77 -9.91 51.06 0.998
12.4 -57.5 -152.58 -10.18 55.66
90.4 -76.26 -208.92 -11.47 62.19
268.0 -78.03 -214.47 -11.51 64.92
599.0 -78.63 -216.3 -11.54 67.17
Con GC 9.3 -70.91 -186.45 -13.08 65.35 0.997
17.9 -75.1 -198.86 -13.43 67.33
98.9 -83.62 -223.66 -14.26 72.43
9 -76.02 -201.3 -13.58 65.62
41.9 -82.7 -220.92 -14.18 70.09
110.0 -82.94 -221.84 -14.14 72.5
922.0 -99.88 -270.81 -15.89 77.69
Cont C-G 15.7 -46.06 -115.37 -10.27 62.15 0.999
32.8 -54.89 -141.83 -10.9 64.97
118.0 -62.74 -165.3 -11.47 69.2
764.0 -82.06 -221.21 -13.45 75.33
Cont A-T 10.1 -61.99 -162.81 -11.49 60.7 0.999
15.8 -65.73 -174.07 -11.74 62.12
635.0 -81.21 -220.53 -12.81 72.18
Table 3.5 continued
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759.0 -74.14 -199.67 -12.21 73.38
Ind-A 6.2 -35.66 -97.59 -5.39 20.56 0.989
12.5 -30.8 -81.41 -5.55 23.43
47.2 -53.01 -151.27 -6.1 36.76
953.0 -42.29 -115.66 -6.42 53.51
Ind-C 3.5 -24.33 -58.47 -6.19 18.5 0.992
18.7 -2129 -67.14 -6.47 34.3
38.1 -43.49 -117.24 -7.13 43.2
145.1 -52.58 -144.1 -7.91 52.2
Ind-G 7.1 -30.23 -76.86 -6.39 27.88 0.99
14.2 -30.17 -75.76 -6.68 34.94
50.4 -43.44 -117.8 -6.9 42.84
908.0 -98.48 -283.1 -10.68 58.43
Ind-T 13.8 -32.59 -82.81 -6.9 37.06 0.986
30.0 -37.6 -97.8 -7.26 44.1
103.0 -43.33 -115.6 -7.48 50.6
Pzl-A 4.9 -38.59 -108.77 -4.86 16.88 0.995
11.3 -47.48 -138 -4.68 22.43
22.8 -42.55 -121.79 -4.78 24.36
82.7 -42.53 -121.73 -4.77 29.73
445.0 -50.71 -147.37 -5 38.52
Pzl-C 15.2 -23.12 -61.05 -4.18 5.02 0.999
Table 3.5 continued
56
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
70.5 -24.89 -68.12 -3.76 12.52
423.0 -29.53 -83.87 -3.52 24.26
1155.0 -28.24 -79.8 -3.49 29.68
Pzl-G 8.4 -19.22 -45.6 -5.08 6.15 0.994
30.1 -19.64 -47.12 -5.03 16.51
72.6 -24.99 -66.48 -4.37 19.37
814.5 -37.25 -106.28 -4.29 36.23
Pzl-T 13.0 -25.99 -68.85 -4.64 11.83 0.988
19.5 -23.53 -59.79 -4.99 16.17
90.3 -31.14 -85.34 -4.67 26.73
210.5 -29.22 -79.61 -4.53 29.85
PzN-A 5.9 -35.91 -97.94 -5.53 21.55 0.994
9.6 -37.1 -101.15 -5.69 25.53
53.7 -45.53 -128.5 -5.67 34.39
PzN-C 5.2 -37.84 -107.36 -4.55 14.55 0.996
10.4 -26.25 -67.6 -5.28 17.04
48.9 -34.51 -95.13 -5.01 27.36
71.2 -44.77 -129.5 -4.61 28.39
184.0 -59.74 -175.9 -5.19 36.41
PzN-G 7.9 -37.98 -108.44 -4.35 15.03 0.992
15.2 -37.36 -105.36 -4.68 20.09
91.2 -40.9 -118.35 -4.2 25.79
Table 3.5 continued
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701.0 -38.9 -109.1 -4.25 35.16
PzN-T 6.8 -21.45 -50.93 -5.65 14.55 0.996
19.9 -28.03 -73.39 -5.27 22.22
95.3 -33.58 -92.74 -4.81 28.97
805.0 -43.17 -122.4 -5.16 42.64
PzP-A 7.6 -35.69 -96.86 -5.64 23.54 0.997
13.8 -33.38 -89.63 -5.59 25.28
24.6 -37.43 -102.75 -5.56 29.06
194.2 -33.97 -91.36 -5.63 40.39
295.8 -49.35 -140.62 -5.74 41.66
578.1 -69.61 -203.43 -6.52 45.84
PzP-C 12.6 -16.43 -34.7 -5.67 14.47 0.998
80.2 -18.04 -42.19 -4.95 22.84
225.0 -19.66 -48.91 -4.49 26.51
430.0 -24.44 -65.4 -4.16 29.3
PzP-G 9.6 -30.58 -80.19 -5.71 23.32 0.997
17.4 -36.96 -101.1 -5.6 27.61
1566.0 -49.99 -143.62 -5.45 46.4
PzP-T 8.5 -19.04 -43.5 -5.54 12.24 0.999
59.2 -31.81 -87.62 -4.63 24.24
277.0 -47.28 -13.643 -4.97 36.47
PzT-A 14.4 -39.82 -108.29 -6.24 32.13 0.989
Table 3.5 continued
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23.9 -42.89 -117.68 -6.4 35.82
91.2 -49.39 -138.65 -6.38 41.13
210.4 -50.58 -142.13 -6.5 45.08
775.1 -53.84 -153.09 -6.36 48.65
PzT-C 3.9 -3627 -101.3 -4.85 14.61 0.977
11.4 -33.74 -90.23 -5.75 25.81
478.0 -88.75 -269.1 -5.29 36.45
314.0 -40.85 -114.23 -5.42 40.47
PzT-G 1.3 -41.33 -111.82 -6.65 24.7 0.994
7.3 -42.42 -114.65 -6.87 33.91
18.5 -47.89 -132.19 -6.89 38.15
56.5 -53.61 -150.19 -7.02 42.88
133.8 -44.83 -122.86 -6.72 45.72
245.7 -55.02 -154.63 -7.06 48.33
PzT-T 4.0 -30.83 -80.12 -5.98 20.94 0.995
14.6 -26.75 -66.74 -6.05 27.87
70.7 -32.56 -86.4 -5.76 35.76
176.0 -50.29 -142.26 -6.16 42.24
388.0 -54.75 -154.9 -6.71 47.98
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Table 3.6 Non-Self-Complementary Sequence Data for each analysis
Sequence Cone.
|j.M
AH
kcal/mol
AS 
cal/mol K
AG
kcal/mol
T m
°C
R
value
Control 2.03 -160.06 -438.66 -24.01 69.24 0.998
15.7 -117.53 -315.52 -19.67 72.25
26.9 -120.62 -324.72 -19.91 72.93
63.6 -112.95 -303.3 -18.89 74.13
174.8 -102.76 -273.94 -17.49 75.33
Ind-1 0.42 -104.6 -278.48 -18.24 63.86 0.999
5.29 -109.81 -294.16 -18.58 68.88
55.4 -96.19 -254.42 -17.28 74.55
Ind-2 3.01 -119.73 -328.05 -17.99 63.12 0.997
28.8 -97.6 -263.83 -15.77 66.5
533 -54.27 -139.21 -11.09 72.61
Ind-3 0.156 -68.12 -184.19 -10.99 39.2 0.993
1.18 -55.68 -145.99 -10.4 43.43
12.48 -53.48 -141.02 -9.74 48.59
216.9 -34.99 -87.93 -7.72 52.5
Ind-4 0.351 -13.63 -11.56 -10.04 37.63 0.999
4.49 -21.93 -41.39 -9.09 46.43
38.9 -27.97 -62.08 -8.72 55.93
Ind-l 2.52 -74.43 -194.67 -14.05 60.55 0.991
12.7 -66.05 -170.54 -13.16 64.37
Table 3.6 continued
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120.7 -108.39 -291.7 -17.92 73.84
PzN-2 0.562 -95.05 -255.53 -15.8 58.18 0.989
2.5 -123.25 -339.6 -17.92 61.77
6.41 -100.15 -271.61 -15.91 62.77
11.4 -111.05 -303.41 -16.95 64.61
22 -108.83 -297.05 -16.7 65.77
54.6 -100.61 -273.84 -15.68 66.64
PzN-3 1.54 -62.69 -174.09 -8.69 34.98
7.94 -63.52 -177.01 -8.62 39.58
75.3 -69.46 -196.91 -8.39 44.72
PzN-4 0.895 -61.43 -160.81 -11.55 48.07 0.996
7.6 -55.99 -144.11 -11.29 55.65
12 -61.8 -160.71 -11.96 59.15
PzP-1 0.519 -126.78 -350.42 -18.09 58.82 0.991
10.6 -117.95 -315.22 -17.18 59.73
3.96 -91 -262 -15.74 61.93
36.4 -56.9 -143.78 -12.3 67.87
PzP-2 0.813 -141.83 -394.83 -19.37 60.2 0.999
1.75 -156.3 -438.31 -20.36 61.26
8.045 -156.93 -439.55 -20.6 63.89
77.7 -141.75 -393.58 -19.68 68.3
PzP-3 0.95 -73.27 -207.19 -9.01 35.35 0.999
Table 3.6 continued
61
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
1.79 -85.61 -247.18 -8.94 36.76
8.63 -91.52 -266.09 -8.99 40.24
81.6 -81.12 -233.91 -8.57 44.49
PzP-4 0.99 -83.68 -229.1 -12.63 49.56 0.998
2 -73.46 -196.97 -12.37 52.2
891 -66 -178.02 -10.79 65.75
PzT-l 0.252 -90.04 -238.26 -16.15 58.87 0.988
1.94 -103.97 -280.12 -17.09 63.31
10.5 -99.88 -267.57 -16.89 67.61
17.9 -102.3 -275.04 -17 68.42
PzT-2 0.3 -64.79 -165.82 -13.36 53.39 0.981
2.67 -106.22 -289.26 -16.5 61.38
11.1 -103.64 -282.14 -1614 63.83
11.2 -104.33 -284.36 -16.13 63.64
20.92 -57.11 -144.98 -12.14 64.46
42.86 -102.36 -278.53 -15.97 66.61
PzT-3 0.787 -63.46 -173.64 -9.6 37.42 0.991
2.65 -71.3 -198.99 -9.59 40.6
7.09 -74.33 -208.13 -9.78 43.88
12.24 -70.83 -197.57 -9.55 44.75
23.84 -68.64 -191.57 -9.22 45.4
69.5 -77.28 -218.47 -9.52 48.52
Table3.6 continued
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PzT-4 0.71 -69.13 -182.47 -12.54 50.88 0.992
2.81 -71.74 -190.27 -12.72 55.28
12.9 -55.36 -142.03 -11.31 58.07
25.2 -66.99 -177.31 -11.99 59.94
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Chapter 4
Enzymic Behavior o f Pyrazole-Containing Nucleobase Analogs with 
Various Thermostable DNA Polymerases
4.1 Target for PCR Reactions
The goal o f this research is to determine the ability o f polymerases to 
recognize the pyrazole analogs. We studied 4-nitropyrazole (PzN) and 4-(2- 
thiazolyl)-pyrazole (PzT)of the pyrazole analogs as well as 2 other well-studied 
modifications, 5-nitroindoIe (Ind) and 3-nitropyrroIe (PyN). (Figure 4.1) Two 
different control experiments were designed. The first control experiment uses a 
non-modified primer containing the natural complement (G) to the position on the 
template. The second control experiment uses 4 identical primers except in the 
position of interest. Each primer contains one o f each o f  the four natural nucleosides. 
These four primers are added in equal mole amounts to allow for quantitation o f  a 
mixture that should be 25% o f  each.
H° ^ p
oCT
NO
HO
HO HO HO HO
Ind PzN PyN PzT
Figure 4.1 Analogs studied in PCR reactions 
4.2 Design o f Enzymic Experiment
Using a procedure originally described at Purdue University by Davisson and
coworkers,! the expression vectorphisF-tac p lasm id^  is digested using the
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restriction endonuclease, Pvu n .  One o f  the fragments from this digestion contains 
the hisF  gene indicated in capital letters (Figure 4.3). This gene serves as part o f a 
797 bp template for the PCR amplification experiments. The Pvu n  recognition site 
is 5'-CAGACTG-3\ When this sequence is present the enzyme will cut the dsDNA 
between the G and C. The sense primer (40 bases) is designed for positions -10 to 30 
o f the hisF  gene (underline on the top portion o f  Figure 4.3). The modification is in 
position 26. The antisense primer (30 bases) is corresponds to positions 757 to +10 
(underlined on the bottom o f Figure 4.3). The hisF  gene is shown in capital letters. 
The modifications were incorporated using standard automated DNA synthesis once 
the phosphoramidites o f  the analogs were either purchased or synthesized as 
described in Chapter 2. During PCR the modified primers are initially extended 
resulting in full-length template containing the modification. The next round o f  PCR 
actually incorporates a natural nucleoside across from the pyrazole analog. Figure
4.2 is a pictorial representation o f this process. This figure is very similar to Figure
1.7 describing PCR except for the pyrazole analogs present in the sense primers. 
Several different enzymes were chosen for this study. These include AmpliJaq® 
DNA polymerase (Perkin-Elmer), Vent DNA polymerase (New England Biolabs), 
Deep Vent DNA polymerase (New England Biolabs), Pfu DNA polymerase exo+, 
Pfu DNA polymerase exo-, and UlTma DNA polymerase (Perkin Elmer). As 
enzymes have different inherent abilities a wide variety o f  enzymes were chosen to 
determine the directing ability o f  the analogs. The question to be answered was 
whether the analogs directed specifically for one base or was it dependent on the 
enzyme’s inherent properties. See Table 4.1 for a list o f  the exonuclease properties
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of the DNA polymerases studied. The different type o f exonuclease activities is 
discussed in Section 1.5.4.
PCR Amplification to Produce DNA 
that Contains a Non-Natural Nucleotide
c
G
separate strands by heating to 95°C
Anneal primers by cooling to 37°C
Q
C
Heat to 70°C to allow for extension
Q
C
c
G
Cycle Repeats
separate strands by heating to 9S°C 
-  Q
C
G
Anneal primers by cooling to 37°C
Q
C
QC
Heat to 70°C to allow for extension
Q i
C
Cycle Repeats
Figure 4.2 Diagram  of PCR reaction containing a pyrazole analog in the
sense p rim er
The fidelity o f  these enzymes is described by the number o f mutations/ bp/ 
duplication.^ UlTma is a very poor proofreading enzyme resulting in such a fidelity 
it is almost considered a  non-proofreading enzyme. The best proofreading enzyme 
studied was Pfu exo+ followed by Vent and then Deep Vent.
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aggaatt.catATGCTGGCAAAACGCATAATCCCATGTCTCGACGTTCGTGATGGTCAGGT
tccttaagtaTACGACCGTTTTGCGTATTAGGGTACAGAGCTGCAAGCACTACCAGTCCA
CCACTTTCCCGTACAGTTTCGCAACCATGAAATCATTGGCGATATCGTGCCGCTGGCAAAA
GGTGAAAGGGCATGTCAAAGCGTTGGTACTTTAGTAACCGCTATAGCACGGCGACCGTTTT
CGCTACGCTGCGATGCGAGCTGACGAACTGGTGTTCTACGATATCACCGCTTCCAGCGATG
GAAGAAGGCCTTCTTCCGCGACTGCTTGACCACAAGATGCTATAGTGGCGAAGGTCGCTAC
GCCGTGTGGTAGATAAAAGCTGGGTATCTCGCGTGGCGGAAGTGATCGACATTCCGTTTTG
CGGCACACCATCTATTTTCGACCCATAGAGCGCACCGCCTTCACTAGCTGTAAGGCAAAAC
TGTGGCGGGTGGGATTAAGTCTCTGGAAGATGCCGCGAAAATTCTTTCCTTTGGCGCGGAT
ACACCGCCCACCCTAATTCAGAGACCTTCTACGGCGCTTTTAAGAAAGGAAACCGCGCCTA
AAAATTTCCATCAACTCTCCTGCGCTGGCAGACCCAACATTAATTACTCGCCTGGCCGATC
TTTTAAAGGTAGTTGAGAGGACGCGACCGTCTGGGTTGTAATTAATGAGCGGACCGGCTAG
GCTTTGGCGTGCAGTGTATTGTGGTCGGTATTGATGGAAACGCTCGACTGGGTACAGGAAG
CGAAACCGCACGTCACATAACACCAGCCATAACTACCTTTGCGAGCTGACCCATGTCCTTC
TGCAAAAACGCGGTGCCGGAGAAATCGTCCTCAATATGATGAATCAGGACGGCGTGCGTAA
ACGTTTTTGCGCCACGGCCTCTTTAGCAGGAGTTATACTACTTAGTCCTGCCGCACGCATT
CGGTTACGACCTCGAACAACTGAAAAAAGTGCGTGAAGTTTGCCACGTCCCGCTGATTGCC
GCCAATGCTGGAGCTTGTTGACTTTTTTCACGCACTTCAAACGGTGCAGGGCGACTAACGG
TCCGGTGGCGCGGGCACCATGGAACACTTCCTCGAAGCCTTCCGCGATGCCGACGTTGACG
AGGCCACCGCGCCCGTGGTACCTTGTGAAGGAGCTTCGGAAGGCGCTACGGCTGCAACTGC
GCGCGCTGGCAGCTTCCGTATTCCACAAACAAATAATCAATATTGGTGAATTAAAAGCGTA
CGCGCGACCGTCGAAGGCATAAGGTGTTTGTTTATTAGTTATAACCACTTAATTTTCGCAT
CCTGGCAACACAGGGCGTGGAGATCAGGATATGTTAacccgggtacg ( 7 97 )  
GGACCGTTGTGTCCCGCA CCTCTAG TCCTA TA CA ATtgqqcccatgc
Figure 4.3 Sequence o f the target PCR product, the hisF  gene.*
Table 4.1 Exonuclease properties o f DNA polymerases
DNA Polymerase 3'- 5' exonuclease 
(proof-reading)
5 '-3 '  
exonuclease
Fidelity3
AmpliTaq® - + 8 x l 0 >
Pfu exo - + sxio-05
UlTma® + + 5x10-°*
Pfu exo+ + + 1.3x1 O'™
Vent + + 2.7 x 10-™
Deep Vent + + 2.8 x 10^
68
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
4.3 Analysis o f PCR Products
The technique most often used to analyze the completed PCR reaction is gel 
electrophoresis using a sieving medium such as agarose. The crude PCR reaction 
will have unused primers (30mer and 40mer) and full length product (797bp) as well 
as buffers present. A  small portion of the PCR reaction is combined with a loading 
buffer consisting o f  2 dyes which migrate at different rates and a reagent Ficoll which 
is used to “weigh” down the solution to aid in loading the samples into the wells. 
Electrophoresis is used to separate the DNA to determine the size o f  the DNA present 
in the PCR reaction. Size markers are used to determine the size o f  the DNA found 
in the PCR reaction. Ethidium bromide is used to visualize the agarose gel.
Ethidium bromide is a DNA intercalator and is visible under UV light when 
intercalated into DNA. An inverted image o f an agarose gel is present in Figure 4.5, 
Figure 4.6, Figure 4.7 and Figure 4.8.
4.4 Sequencing o f PCR Product
Once the PCR reaction is complete, the sequence o f the antisense strand 
needs to be determined. This sequence will indicate the ratio o f natural nucleotides 
incorporated across from the pyrazole analog. The sequence of the antisense strand 
will be determined using the Sanger Method as described in Section 1.4.3.
4.5 Results
4.5.1 PCR Reactions
The PCR reactions using the modified nucleoside analogs were successful as 
indicated by full-length product in the agarose gel. Figures 4.5-4.8 are analytical
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agarose gels showing the results o f  each PCR reaction with the individual primers 
with each different enzyme.
Analysis of How the Analog Was Recognized 
by the Thermostable DNA Polvmerase
a-^P-ddNTP’s i Dideoxy Sequencing Using the Thermosequenase Kit
33p
33p
33p
33p
33p
33p
8% PAGE of Sequencing Products
•Gel result yields 
informaticHi about 
how die analog 
was recognized by 
the polymerase.
•The recognition o f 
the analog is 
then translated to 
percent dNMP 
incorporation.
A C G T
Position on the 
gel where the 
information is 
obtained about 
analog 
recognition.
Figure 4.4 Schematic diagram of Sanger method for sequencing
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Figure 4.5 Agarose gel analyzing PCR reactions with AmpliTaq® and UlTma 
enzymes with control primer (C), 5-nitroindole (Ind) primer, 4-nitropyrazole 
(PzN) primer, 3-nitropyrrole (PyN) primer and 4-(2-thiazolyl)-pyrazole (PzT) 
primer
Figure 4.6 Agarose gel analyzing PCR reactions with Pfu exo+ and Ffu  exo- 
Enzymes with control primer (C), 5-nitroindole (Ind) primer, 4-nitropyrazole 
(PzN) primer, 3-nitropyrrole (PyN) primer and 4-(2-thiazolyl)-pyrazoIe (PzT) 
primer
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Figure 4.7 Agarose gel analyzing PCR reactions with Deep Vent and Vent 
enzymes with control primer (C), 5-nitroindole (Ind) primer, 4-nitropyrazole 
(PzN) primer, 3-nitropyrrole (PyN) primer and 4-(2-thiazolyl)-pyrazole (PzT) 
primer
Lambda
p-Gem
I I
Con PzN PzT Con PzP PzT Con. PzN PzT Con PzP PzT ***2027 bp
831 bp
797 bp
■^ —primer
Figure 4.8 Agaorse gel analyzing PCR reactions with AmpliTaq® enzyme with 
control Primer (Con), 4-nitropyrazole primer (PzN), 4-propynyl pyrazole 
primer (PzP), and 4-(2-thiazoIyl)pyrazole primer (PzT)
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4.5.2 Sequencing of PCR Products
Sequencing o f the PCR products was successful using Thermo Sequenase 
Radiolabeled Terminator Cycle Sequencing Kit (Amersham/USB). Analysis o f the 
sequencing reaction again used gel electrophoresis yet acrylamide/bisacrylamide was 
used as the separation medium. This is more appropriate for shorter strands o f  DNA 
when compared with agarose. When using the PCR product from the reaction with 
the control sense primer, the position o f  interest should show G. With modified 
primers other bases can be incorporated as shown in Figure 4.8. In most instances 
with non-proofreading enzymes, T was incorporated across from PzN and PzT. 
Proofreading enzymes tended to remove the analogs but not with total efficiency.
4.5.3 Quantitation o f Acrylamide Gel Sequencing Results
The results of this research are ultimately determined by quantitation o f  the 
gels o f the sequencing reactions. One o f  the actual gel images used for quantitation 
is included for each primer and each enzyme in Figure 4.8 Pfu exo-, Figure 4.9 
A m plify® , Figure 4.10 Vent, Figure 4.10 Deep Vent, and Figure 4.12 Pfu exo+, 
and Figure 4.14 UlTma. The analysis o f  the gels was performed using ImageQuant 
by Molecular Dynamics. Table 4.2 contains the relative amount o f  dNMP 
incorporated into the antisense strand across from the modification. ( Note: the gel 
image contains the complement to the base found on the PCR product.)
Coo Irxl PZN PyN
A C G T A C G T A C G T A C G T
-  —  “
“ < * -
IIIII
-  S < -
■ 5
PZT
A C G T
Figure 4.9 Sequencing o f PCR products from Pfu exo- enzyme
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Figure 4.10 Sequencing gels o f  PCR products from AmpliTaq®
Figure 4.11 Sequencing gels o f  PCR products from Vent enzyme
Figure 4.12 Sequencing o f PCR products from Deep Vent enzyme
Con Ind PzN PyN
A C G T A C G T A C G T A C G T
— — _ " i i . “3 . T #
^  -z<-
" 3 s 2 2
PzT 
A C G T
Figure 4.13 Sequencing o f PCR products from Pfu exo+ enzyme
Con
A C G T
£
Ind PZN
A C G T A C G T
-  9
m  ** •  m•*
0  4 -
I
PyN
A C G T
W
Figure 4.14 Sequencing G el o f  PCR products from UlTma enzyme
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Table 4.2 % dNMP Incorporated into PCR Reactions Using Primers
Containing M odification in place of G
Enzyme AmpliTaq®
(-)
Pfu exo- Deep 
Vent (+)
Vent(+) Pfu exo+ UlTma (+)
Primer
Control
(G)
A 3(1) 
C 96 (2) 
G 1 (1) 
T 0 (0)
A 7.5(1) 
C 91.5(2) 
G 0 (0)
T 1 (1)
A 1 (2) 
C 99 (2) 
G 0 (0) 
T 0 (0)
A 0 (0) 
C 82 (8) 
G 18 (8) 
T 0 (0)
A 2 (2) 
C 98 (2) 
G 0 (0) 
T 0 (0)
A 0 (0) 
C 92(10) 
G 1 (1) 
T 7 (11)
Ind A 51 (4) 
C 22(20) 
G 26(20) 
T 1 (1)
A 15(3) 
C 27 (1) 
G 29 (1) 
T 29 (5)
A 31 (37) 
C 65 (37) 
G 1 (2) 
T 3 (2)
A 48(15) 
C 52 (15) 
G 0 (0)
T 0 (0)
A 3 (4) 
C 96 (3) 
G 1 (2) 
T 0 (0)
Not
determined
PzN A 94(2) 
C 4 (1) 
G 2 (1) 
T 0 (0)
A 99 (2) 
C 0 ( 0 )  
G 1 (2) 
T 0 (0)
A 15(13) 
C 85(13) 
G 0 (0) 
T 0 (0)
A 7(7) 
C 93 (7) 
G 0 (0) 
T 0 (0)
A 10(6) 
C 77(10) 
G 4 (4) 
T 9 (8)
A 99(1) 
C 1 (1) 
G 0 (0) 
T 0 (0)
PyN A 83 (4) 
C 2 (2) 
G 3 (2) 
T 12(8)
A 45 (13) 
C 18 (8) 
G 10 (3) 
T 25 (14)
A 7(12) 
C 87 13) 
G 1 (2) 
T 5 (4)
A 51 (22) 
C 43 (21) 
G 2 (2) 
T 5 (3)
A 2 (1) 
C 98 (2) 
G 0 (0) 
T 0 (0)
A 97(6) 
C 0 (1) 
G 3 (5) 
T 0 (0)
PzT A 93 (6)
C 5 (5 ) 
G 1 (1) 
T 0 (0)
A 100(0) 
C 0 (0) 
G 0 (0) 
T 0 (0)
A 28 (2) 
C 63 (2) 
G 6 (2) 
T 3 (2)
A 80 (6) 
C 18 (9) 
G 2 (4) 
T 0 (0)
A 8(4) 
C 91 (5) 
G 1 (1) 
T 0 (0)
A 96(8) 
C 4 (8) 
G 0 (0) 
T 0 (0)
25%A/
C/G/T
A 26 (8) 
C 32 (5) 
G 23 (8) 
T 19(5)
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4.6 Discussion
Non-proofreading enzymes AmpliTaq€> and Pfu- mainly paired an A with the 
pyrazole analogs. This would agree with the thermodynamic analysis indicating the 
pyrazole analogs show a preference for pairing with A. Bergstrom and coworkers
report mainly A incorporation across from an abasic site. 1 Our research found 
mixtures o f  the nucleotides incorporated across from Ind and PyN. The ratio of
nucleotides for PyN is very similar to those found by Bergstrom. * A possible 
explanation o f  a purine/pyrimdines mixture is the ability o f  the base to rotate about 
the glycosidic bond in an anti-syn configuration, allowing for size accommodations 
depending on the pairing partner. The pyrazole analogs are unable to have this 
rotation due to the placement of the substituents on the 4-position. The position of 
the substituents, although the entire molecule is no larger than indole, would disturb 
the complementary chain is the other conformation is adopted.
Two control experiments were performed. This first contained the natural 
complement, G, in the primer to the base in the template strand. The first control 
allows us to determine whether the polymerase and all the other reagent were correctl 
added. This also provides a contrasting base in the sequencing reaction as to what 
base we expected to be incorporated. If  our analogs were expected to direct for a C 
in the PCR reaction it would be difficult to detect. With the proof reading enzymes, 
it the modification was removed from the initial primer and replaced with the natural 
complement to the template, a G is indicated in the sequencing reaction. I f  the 
modification is not removed then something other than G normally has been
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observed. The second control experiment used each natural base in place of the 
modification in equal amounts provided close to 25% with error o f  each base. (Noted 
in Table 4.2 as 25%A/C/G/T) The C base had a slightly higher amount but this is the 
natural complement allowing possibly for better annealing as well as ease of 
extension o ff o f a mismatch. Proofreading enzymes, Deep Vent, Vent and Pfu+, 
removed all o f  the analogs but with varying efficiency. If  the modifications are not 
removed an A  is incorporated across from the pyrazole analog. The exception to the 
proofreading enzymes is UlTma. UlTma does not remove modifications and 
incorporates an A with the analogs. These results indicate the pyrazole analogs direct 
for exclusively A incorporation with the enzymes studied whereas Ind and PyN do 
not exclusively direct for one o f the natural bases.
Another explanation o f incorporation o f  A across from the pyrazole analogs 
could be suggested as the “A-rule” possessed by some enzymes.^ The “A-rule” 
suggests if  an enzyme does not recognize the modification then an A will be
incorporated as a “fail safe” and the polymerization will continue.^ Polymerases 
extend off an A-mismatch with better efficiency than any o f  the other bases and thus 
“A” incorporation may reflect selective amplification of thie m i s m a t c h . 5 - 6  
Exonuclease activity can remove abnormalities 5 bases back from the 3' end. This 
position o f our modification in the primer was such that exonuclease activity could 
remove it. Depending on the enzyme, the non-natural analogs were tolerated to 
varying degrees. The sequencing does not indicate evidence o f the polymerase 
skipping or looping out the pyrazole analog.
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Insertion o f  A across from the pyrazole analogs seems to be favored. Although 
thermodynamic data supports A as the base favored across from the pyrazoles, the 
fail safe insertion o f A by the polymerases cannot yet be ruled out. To determine if  
the pyrazole analogs are actually directing for A to be incorporated, kinetic 
experiments will need to be performed to determine the rate o f  insertion for the 
natural nucleotides against the pyrazole analogs.
Figure 4.15 Schematic o f 3'->5' Exonuclease Activity Removing the 
Modification Q from the Primer and Replacing with a Natural Nucleotide.
Related to the kinetic question is whether termination of the extension is 
occurring across from or immediately following the modification and to what extent. 
If termination were occurring, the position of termination would provide useful 
information about the “reading” efficiency by various polymerasesof the analogs. A 
shortcoming o f  the original experimental design does not allow for the determination
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of whether the polymerase is inserting across from the analog and then stalling on the 
next insertion or if  the polymerase is stalling at the modification. An assay which 
involves a fluorescently labeled antisense primer is being used to probe this topic. 
This primer results in shorter products (237 bp) which are simpler to analyze due to 
their size as well as the fluorescent label, which allows for more convenient analysis. 
According to preliminary results some termination is occurring.
4.7 Experimental
4.7.1 PCR Reactions
4.7.1.1 Preparation of Template
Pvu H restriction endonuclease was used to digest phisF-tac plasmid, 
generously provided by Davisson and coworkers,! at Purdue University into the hisF 
gene (797bp) (Figure 4.3) following the protocol provided by Promega with the 
enzyme (Table 4.3). The Pvu II recognition site is 5,-CAGACTG-3'. Once the 
reagents were added the reaction was incubated at 37 °C for 1 hour and then diluted
10 fold to a final concentration of 20 finol/ pL.
Table 4.3. Conditions for Digesting >his-F-tac plasmid with Pvu II
Reagent Stock
Concentration
Volume
pL
Final Concentration 
(50pL)
h 2o 41.75
phis-F tac 1.7pg/pL 1.25 42.5ng/pL
PVU II 10 Units/ pL 2 20 Units
10X NEBuffer 2 500mM NaCl 
lOOmM Tris-HCl 
lOOmM MgCl2 
lOmMDTT
5 50mM NaCl 
lOmM Tris-HCl 
lOmM MgCl2 
ImMDTT
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4.7.1.2 Synthesis o f Primers
Most primers were synthesized by Midland Certified Reagent Company using 
standard automated DNA chemistry and purified by AE-HPLC. Several primers 
were synthesized at LSU. These were prepared using the same procedure as for the 
oligomers used in the thermal denaturation studies. See Section 2.3.2.
4.7.1.3 Sequence o f Primers 
Forward Sense Primer fo r  PCR
5’ AGG AAT TCA TAT GCT GGC AAA ACG CAT AAT CCC ATQ TCT C3’
Q= G control
4-nitropyrazole nucleotide,
4-propynylpyrazole nucleotide,
4-(2-thiazolyl)pyrazole nucleotide
5-nitroindole nucleotide 
Antisense Primer fo r  PCR
5’ CGT ACC CGG GTT AAC ATA TCC TGA TCT CCA 3’
4.7.1.4 Conditions for PCR Reactions
The enzymes and respective buffers were purchased from commercial sources
with one exception. UlTma was originally purchased from Perkin-Elmer and then a 
generous gift by Dr. Gefland supplied enough enzyme to complete the experiments. 
The commercial sources for each enzyme are: Ampli Ta^r® DNA polymerase (Perkin- 
Elmer), Vent DNA polymerase (New England Biolabs), Deep Vent DNA polymerase 
(New England Biolabs), Pfu DNA polymerase exo+, Pfu DNA polymerase exo-, and 
UlTma DNA polymerase (Perkin Elmer). The dNTP’s were purchased from Roche. 
The following reagents were added into a 200 pL reaction tube. The reagents and
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reaction tube were kept on ice until added to the thermal cycler heating block at 75 
°C. The reaction was mixed thoroughly between each addition in the order listed. 
The cycle for the reaction included an initial warm up o f 94 °C for 5 min., followed 
by 32 cycles o f 95 °C for 30 seconds, 37 °C for 30 seconds and 70 °C for 1 min., and 
a final 10 min. extension at 70 °C and then temperature was lowered to 4 °C until 
further workup.
Table 4.4 Ampli7gy<S> PCR Conditions
Reagent Stock
Concentration
Volume
pL
Final Concentration 
(lOOpL)
h 2o 52.5
1 OX PCR 
Buffer II
500mM KC1, 
lOOmM Tris- 
HC1, pH 8.3
10 50mM KC1, lOmM Tris- 
HC1
dNTP's 2mM total of 
each
10 200pM
Forward Primer 
(Modified)
lOpM 10 lpM
Antisense
Primer
lOpM 10 lpM
MgCl2 Solution 25mM MgCl2 6 1.5mM MgCl2
phis-F-tac
digested
plasmid
finol quantities of 
template
1 finol quantity
AmpliTaq®
Polymerase
5 Units/pL 0.5 2.5 Units
Table 4.5 Vent PCR Conditions
Reagent Stock Concentration Volume
pL
Final Concentration 
(lOOpL)
h 2o 58
10X ThermoPol 
Reaction Buffer
lOOmM KC1, 
lOOmM (NH4)2S04, 
200mM Tris-HCl 
(pH 8 .8  @25 °C) 
20mM MgS04 
0.1%TritonX-100
10 lOmM KCl,
10 mM (NH4)2S 0 4, 
20mM Tris-HCl
2mM MgSQ4
Table 4.5 continued
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dNTP's 2mM total o f  each 10 200pM
Forward Primer 
(Modified)
lOpM 10 lpM
Antisense
Primer
lOpM 10 lpM
phis-F-tac
digested
plasmid
finol quantities o f  
template
1 finol quantity
Vent DNA 
Polymerase
2 Units/pL 1 1 Unit
Table 4.6 Deep Vent PCR Conditions
Reagent Stock Concentration Volume
pL
Final Concentration 
(lOOpL)
h 2o 58
lOXThermoPol 
Reaction Buffer
lOOmM KC1, 
lOOmM (NH4)2S 0 4, 
200mM Tris-HCl, 
(pH 8.8  @25 °C) 
20mM MgS04 
0.1%Triton X-100,
10 lOmM KC1,
10 mM (NH4)2S 0 4, 
20mM Tris-HCl,
2mM M gS04,
dNTP's 2mM total o f each 10 200pM
Forward Primer 
(Modified)
lOpM 10 lpM
Antisense
Primer
lOpM 10 lpM
phis-F-tac
digested
plasmid
finol quantities o f  
template
1 finol quantity
Deep Vent 
DNA
Polymerase
2 Units/pL I lU n it
Table 4.7 Cloned Pfu exo+ PCR Conditions
Reagent Stock Concentration Volume
pL
Final Concentration 
(lOOpL)
H20 58
dNTP's 2mM total o f  each 10 200pM
Forward Primer 
(Modified)
lOpM 10 lpM
Table 4.7 continued
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
10X ThermoPol 
Reaction Buffer
lOOmM KC1, 
lOOmM (NH4)2S 0 4, 
200mM Tris-HCl 
(pH 8 .8  @25 °C) 
20mM M gS04 
l%Triton X-100,
1 mg/ml nuclease- 
free bovine serum 
albumin
10 lOmM KCl,
10 mM (NH4)2S 0 4, 
20mM Tris-HCl
2mM MgS04
Antisense
Primer
lOpM 10 lpM
phis-F-tac
digested
plasmid
finol quantities o f 
template
1 finol quantity
Cloned Pfu+ 
DNA
Polymerase
2.5 Units/pL 1.25 1 Unit
Table 4.8 Recombinant Pfu exo- PCR Conditions
Reagent Stock Concentration Volume
pL
Final Concentration 
(lOOpL)
h 2o 58
10X ThermoPol 
Reaction Buffer
lOOmM KCl, 
lOOmM (NH4)2S 0 4, 
200mM Tris-HCl 
(pH 8 .8  @25 °C) 
20mM M gS04 
l%Triton X-100,
1 mg/ml nuclease- 
free bovine serum 
albumin
10 lOmM KCl,
10 mM (NH4)2S 0 4, 
20mM Tris-HCl
2mM MgS04
dNTP's 2mM total o f each 10 200pM
Forward Primer 
(Modified)
lOpM 10 lpM
Antisense
Primer
lOpM 10 lpM
phis-F-tac
digested
plasmid
finol quantities o f 
template
1 finol quantity
Recombinant 
Pfu- DNA 
Polymerase
2.5 Units/pL 1.25 lU n it
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Table 4.9 U1 Tma PCR Conditions
Reagent Stock Concentration Volume
pL
Final Concentration 
(lOOpL)
h 2o 52.5
1 OX PCR 
Buffer
lOOmM KCl, 
lOOmM Tris-HCl, 
pH 8 .8 )
10 lOmMKCl 
lOmM Tris-HCl
dNTP's 2mM total o f each 10 200pM
Forward Primer 
(Modified)
lOpM 10 lpM
Antisense
Primer
lOpM 10 lpM
MgCl2 25 mM MgCl2 6 1.5 pM MgCl2
phis-F-tac
digested
plasmid
finol quantities of 
template
1 finol quantity
UlTma 6  Units/pL 0.5 3 Unit
4.7.1.5 Gel Electrophoresis of PCR Products.
The products from the PCR reaction were separated and visualized using
agarose gel electrophoresis (BioRad). The samples were loaded onto a 1% (mol / v) 
agarose gel with a  buffer o f  Tris-Acetate-EDTA (TAE)(0.04 M Tris-Acetate, 0.001 
M EDTA). The gel was prepared by dissolving 1 g o f  agarose in 75 mL o f IX TAE 
(0.04 M Tris-Acetate, 0.001M EDTA) by heating. Once all the agarose was 
dissolved, 3 pL o f  ethidium bromide was added for later visualization, the warm 
solution was poured into the electrophoresis tray, allowed to cool and solidify into a 
whitish gel. Next, the gle was placed into the electrophoresis tray with buffer and 
loaded with equal volumes o f  the samples and a 2X Load buffer (0.08% 
bromophenol blue, 0.08% xylene cyanol FF and 5% Ficoll (Type 400)). The gel was 
run with 100V applied for 30 minutes or until the first dye marker traveled half the 
distance of the gel. The ethidium bromide intercalated into the DNA and allowed for
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visualization using UV light. Two DNA size markers from Promega were used to 
detemine size o f  PCR products, pGem ®(Catalog # g l7 4 i)  and Lambda DNA/£coR 
I + Hind HI Markers (Catalog #1731), abbreviated as lambda in the figures. The 
source for pGem® DNA markers are made by digesting pGem®-3 DNA to 
completion using H in fl, Rsa I and Sin I. The marker called lambda results from the 
complete digestion o f Lambda DNA with EcoR. I and H ind  m  enzymes.
4.7.1.6 Purification o f PCR Products
Wizard PCR preps (Promega) were used for purification o f the PCR products 
following the manufacture's protocol.
4.7.2 Sequencing Reactions
4.7.2.1 Synthesis o f DNA Primer for Sequencing Reactions
The primer for sequencing was synthesized by Midland Certified Reagent 
Company and purified by AE-HPLC.
Sequence 5’ GAA TTC ATA TGC TGG C 3’
4.7.2.2 Reaction Conditions for Sequencing Reactions
The sequencing primer (pmol) along with the purified PCR products (finol) 
were added to the reagents provided by Thermosequenase™ kit (Amersham). The 
manufacturer’s protocols were followed for sequencing. The thermal cycle required 
for the reaction was provided by the k i t
4.7.2.3 Gel Electrophoresis o f Sequencing Reactions
The quenched reaction products were analyzed under denaturing conditions 
(7 M urea 50-55 °C) using gel electrophoresis (8 %, 19:1 acrlyamide:bisacrylamide)
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under constant voltage (1100 V) on a BioRad Sequi-Gen GT System (0.4 mm x 38 
cm x 30 cm). The gels were cast using the precision cast assembly provided by Bio- 
Rad and equilibrated for lh  before loading. The 4 (A, C, G, T) samples were heated 
to 70 °C and then 4.0 pL  was immediately added to the gel. A positive displacement 
pipette was used to assure the exact same amount o f  sample was added to each o f  the 
four lanes. I f  different amounts were added the quantitation would not be acceptable. 
The gels were run until the bromophenol blue in the loading buffer (provided by  kit) 
had run 75% the length o f  the gel. The gels were then sandwiched between blotting 
paper and Saran Wrap® and dried for 2 h at 80 °C under vacuum on a Bio-Rad 583 
gel dryer. Once the gel had dried and cooled, it was placed on the imaging plate 
(Molecular Dynamics) for 24 h and scanned using Image-Quant (Molecular 
Dynamics) software
4.7.2.4 Quantitation o f Images from  Sequencing Gels
Anaylsis o f  the image was performed using ImageQuant. All four lanes at the 
position the modification was analyzed. To quantitate, a  rectangle was drawn around 
each lane at the position o f  interest. A second rectangle was placed in a position o f 
representative. Each lane was corrected for the background. The software then 
analyzed the four lanes for relative intensities in the lanes. This analysis was 
performed on alteast three separate sequencing reactions. The average o f  the anaylsis 
is reported with the standard deviation.
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Chapter 5 
Synthesis of 2-thiazole C-nucleoside
5.1 Design
Examination o f  the thermodynamic results for 4-(2-thiazolyl)-pyrazole 
(PzT) (Chapter 3) led to an interest in synthesizing 2-thiazole C-nucleoside. The 
thermodynamic data showed PzT  to be the best o f the four pyrazole analogs studied. 
The thiazole substituent provided increased Tm’s with the self-complementary 
sequences when compared to the other three substituents. We would like to 
investigate thiazole as a main heteroaromatic unit in thermodynamic studies as well 
as enzymic studies. Substituted thiazole nucleosides have been studied before
mainly in RNA for their antiviral activity. * ^  Unsubstituted thiazole nucleoside had 
not been previously been synthesized in the literature.
r= \
HO HO
HO HO
Figure 5.1 S tructure o f thiazole nucleoside and thiazole N-oxide nucleoside
Two design features with thiazole as the main heteroaromatic unit are a C- 
nucleoside and the introduction o f  both positive and negative charge in the ring. 
(Figure 2.3) A third design aspect with thiazole offers the ability to prepare an N- 
oxide. It has been shown that modification o f the minor groove binding site o f the 
Klenow fragment markedly decreased the DNA-binding affinity and the rate o f 
DNA synthesis.3-5 it has been proposed by Kool and others that the C-2-oxygen on
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pyrimidines or N-3 in purines in the minor groove is a key feature for recognition by 
DNA p o ly m erases.6  For example, the nucleoside triphosphate o f  3-nitropyrrole 
which lacks a minor groove hydrogen-bond donor, was shown to either inhibit or 
terminate polymerase extension with various p o ly m erases.^ The thiazole N-oxide 
would offer a non-hydrogen-bonding analog that allows for the placement o f  an 
oxygen in the minor groove. Comparison o f  enzyme behavior with the N-oxide 
versus the thiazole compound could provide insight into this theory.
The synthesis o f  the thiazole compound (5c) and N-oxide compound (5d) 
are complete. The crystal structure o f  deprotected 5c has been obtained. 
Incorporation into oligonucleotides has not been attempted. The stability o f  the 
oxide to standard automated DNA chemistry needs to be determined.
5.2 Synthesis
The synthetic approach developed for thiazole C-nucleoside is similar to the 
synthesis o f  compounds l a  and lb  in Chapter 2. The initial difficulty is the 
synthesis o f  a  C-nucleoside. C-nucleosides are much more difficult to when 
compared to N-nucleosides. Sodium cyanide is dissolved in freshly distilled 
dimethoxyethane (DME) and o f 3,5-bis-Op-toluoyl-p-D-2-deoxyribose chloride 
was added portion wise and allowed to stir under inert atmosphere overnight 
forming yellowish salts on the bottom o f the reaction flask. This solvent system
according to the literature afforded a 2:1 ratio o f  (J:a.8 Using freshly distilled DME 
we found almost 95% o f  the (3 anomer. The cyano sugar required only an aqueous 
extraction to provide material pure enough for the next reaction. The next series of
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synthetic steps required the conversion o f  the cyano group into thioamide using H2S 
(g) followed by cyclization using chloroacetaldehyde. This series o f steps is a 
modification o f  the synthesis o f  4-thiazolecarboxamide. 9 This conversion o f  a 
cyano group into thioamide is a very common synthetic procedure condensing H2S 
(g) with the cyano functional group. The crude product from this conversion 
required purification by column chromatography. The final cyclization step 
required refluxing chloroacetaldehye with the thioamide in a  mixture o f
tetrahydrofuran/ethanol.iO Attempts to cyclize without heat were not successful. 
The N-oxide o f  Sc was prepared with exclusive oxidation on the ring nitrogen 
without oxidation o f the ring sulfur as proposed by Hansen and coworkers using m- 
chloroperoxybenzoic acid (MCPBA). 11 This reaction required several days with 
only a modest yield. (Scheme 5.1)
Scheme 5.1 Synthesis o f 2-thiazole Protected C-nucleoside and Thiazole-N- 
oxide C-nucleoside
T0,O^ > c ,
TolO DME
NaCN TolO y O C =N  H2S
4 eqv. V" 'v'
x o ii  5a d m a p
■nh2
TolO 5b
TolO
5dTolO
THF/EtOH 
reflux 24h H
/ = \
MCPBA 
3 days
TolO
TolO
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5.3 Experimental
5.3.1 5-anhydro-3-deoxy-4,6-di-0-/MoiuoyI-P~D-ri&0-hexononitrtle (5a)
Sodium cyanide ( 1.49 g, 0.03 mol) was dissolved in DME (100 mL) freshly 
distilled from Na (s) and benzophenone under Ar. This solution stirred for 30 
minutes followed by the addition o f 3,5-bis-0-p-toluoyl-P-D-2-deoxyribose chloride 
(2.97 g, 7.6 mmol) (Scheme 2.1). The cloudy white solution turned yellowish with 
a small amount o f  solid precipitate when left overnight to stir under inert 
atmosphere. The DME was removed under reduced pressure. Next, the crude 
product was redissolved in ethyl acetate and washed with saturated sodium 
bicarbonate, water and brine, dried and filtered. The solvent was again removed 
under reduced pressure and the yellowish oil (2.56 g, 67%) was used directly in the 
next reaction. Characterization by 'H  NMR (250 MHz, CDCb), 8  7.97 (d, J=8 , 2H 
aromatic), 7.85 (d, J=8 ,2 H  aromatic), 7.20 (d, J=8 , 4H, aromatic), 5.60 (m, 1H, H3),
4.90 (t, J=7.7,1H, H la ), 4.52 (m, 3H, H4, H5, H5'), 2.82 (m, 1H, H2) 2.52 (m, 1H, 
H2'), 2.39 (s, 6H, Ar-CHa). The ratio o f  P:a is 95:5. Characterization o f a  anomer 
by 'H  NMR (250 MHz, CDC13), 8  7.97 (d, J=8 , 2H aromatic), 7.85 (d, J=8 ,2H  
aromatic), 7.20 (d, J=8 ,4H , aromatic), 5.60 (m, 1H, H3), 5.04 (d, J=7Hz, 1H, Hip),
4.52 (m, 3H, H4, H5, H5'), 2.82 (m, 1H, H2) 2.52 (m, 1H, H2’), 2.39 (s, 6H, Ar- 
CHj).
5.3.2 5-anhydro-3-deoxy-4,6-di-0-/Moluoyl-p-D-ri&0-hexonothiainide (5b)
5-anhydro-3-deoxy-4,6-di-0-p-toluoyl-P-D-rifro-hexononitrile, (5a), (2.33 g, 
0.06 mmol) was dried in the reaction vessel overnight under vaccum. Next, DMAP 
(0.05 g, 0.41 mmol) was added, the pressure vessel cooled in a dry ice/acetone bath
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and H2S condensed into the vessel. Once a sufficient amount o f  gas had condensed, 
the vessel was seal and left to warm to room temperature overnight. The vessel was 
cooled again in a  dry ice/acetone bath, opened and allowed to warm to room 
temperature. The orangish oil was dissolved in DCM and transferred to a second 
flask. The DCM was removed under reduced pressure. The crude reaction was then 
dissolved in ether and washed with sodium bicarbonate, water and brine, dried with 
sodium sulfate, filtered, and the solvent removed under reduced pressure. The 
(3 anomer was isolated using silica with 95:5 CHCls/EtOAc (Rf =  0.03) in 27% yield 
(0.68 g, 1.6 mmol). ‘H NMR (250 MHz, CDCI3), 5 8.35 (s, 1H, amide), 7.85 (m,
4H aromatic), 7.57 (s, 1H, amide), 7.20 (d, J=8 , 4H, aromatic), 5.60 (m, 1H, H3),
4.90 (t, J=7.7, 1H, H I), 4.52 (m, 3H, H4, H5, H5’), 2.82 (m, 1H, H2) 2.52 (m, 1H, 
H2 '), 2.39 (s, 6H, Ar-CH3)
5.3.3 2-(3,,5’-Bis-0-p-toluoyl-[3-D-2’-deoxyribosyl)-thiazole (5c)
5-anhydro-3-deoxy-4,6-di-0-p-toluoyl-(3-D-ribo-hexonothiamide, (5b),
(1.16 g, 3.0 mmol) was dissolved in THF (33 mL), ethanol (16 mL) followed by 
chloroacetaldehyde (50% wt. in H2O) (3.18 mL, 25 mmol). This solution was left at 
reflux for 24 h followed by addition o f  a second portion o f  chloroacetaldehyde (3.18 
mL, 25 mmol) with refluxing for 24 h. The solvents were removed under reduced 
pressure. The residue was dissolved in ethyl acetate washed with saturated sodium 
bicarbonate, water and brine, dried with sodium sulfate, filtered and the solvents 
were removed under reduced pressure. Isolation o f  the (3 anomer in 42% yield (0.55 
g, 1.2 mmol) required silica with hexanes/ethyl acetate. *H NM R (250 MHz, CDCI3, 
7.85 (m, 4H aromatic, 1H H4), 7.75 (s, 1H, H5), 7.20 (d, J=8 ,4H , aromatic), 5.60
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(m, 2H, H3\ HI'), 4.52 (m, 3H, H4, H 5\ H5"), 2.82 (m, 1H, H2") 2.52 (m, 1H, H2'), 
2.39 (s, 6H, Ar-CH3)
5.3.4 2-(3,,5,-Bis-0-p-toluoyl-(}-D-2,-deoxyribosyl)-thiazole-3-oxide (5d)
2-(3',5'-Bxs-0-p-toluoyl-P-D-2'-deoxyribosyl)-thiazole (5c) (160 mg, 0.39 
mmol) was dissolved in 2 mL o f  ethyl acetate followed by addition o f  m- 
chloroperoxybenzoic acid (MCPBA) (152 mg, 0.78 mmol). The reaction was 
allowed to stir for 2 days, followed by addition o f a  second portion o f  MCPBA (114 
mg, 0.58 mmol) and left to stir for another 24 h. The reaction was quenched by 
ethyl acetate (25 mL) and sodium bicarbonate (25 mg). The mixture was filtered 
through a pad o f solid sodium bicarbonate. The bicarbonate pad was rinsed with 
ethyl acetate followed by 20% methanol/ethyl acetate until no UV active 
compounds were eluting as indicated by TLC. The solvents were removed under 
reduced pressure and the residue was purified using silica with a gradient o f 0-25% 
ethyl acetate in methanol. The clear oil was isolated in 42% yield. [H NMR (250 
MHz, CDC13, 7.85 (m, 4H aromatic, 1H H4), 7.75 (s, 1H, H5), 7.20 (d, J=8,4H, 
aromatic), 5.60 (m, 2H, H3\ HI'), 4.52 (m, 3H, H4, H5', H5"), 2.82 (m, 1H, H2”)
2.52 (m, 1H, H2'), 2.39 (s, 6H, Ar-CH3)
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Chapter 6 
Substitution of 5-NitroindoIe Nucleotides During Oligonucleotide 
Synthesis
6.1 Introduction
Due to the repetitive cycling o f automated DNA synthesis, it has been 
suggested by Dr. Donald Bergstrom at Purdue University as well as Dr. Lyn Meyers 
at Midland Certified Reagent Company, iodination o f 5-nitroindole occurs by 
replacement o f  the nitro group in the 5 position or addition o f  iodine to the 3- 
position o f  the bicyclic ring. I f  substitution or addition occurred this might affect 
the enzyme behavior and recognition o f primers containing this modification. 
Electrophilic aromatic substitution is the more common route for addition o f 
halogens. Substitution or halogenation o f aromatic systems can follow a radical 
cation mechanism when the appropriate activating substituents are present such as a 
nitro gro u p . The oxidation solution containing iodide, water and pyridine 
provides a source o f I* that could allow for radical collapse and therefore iodination 
o f the indole ring. The presence o f a radical cation might occur if  the 5-nitroindole
ring were to undergo oxidation (oxidation potential 1.59 eV^) due to excess 
reagents not totally removed from the column. The combination o f the aromatic 
substitution and radical cation and addition could alter the characteristics o f the 
indole ring when exposed to enzymes.
6.2 Discussion
Due to the position o f  5-nitroindole in the primer sequence used in Section 
4.7.1.3, the nucleoside is exposed to “excess” amount o f  oxidation cycles, which 
may increase the chance for addition or substitution. The common oxidation
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procedures utilize iodide solutions but a few alternative solutions are available. One 
oxidation alternative is t-butyl peroxide but as this produces radicals much easier 
than I2 solution another alternative was needed. The reagent ultimately used for 
oxidation is (1 S )-(+)-( 10-camphorsulfonyl)-oxaziridine (CSO). Glen Research 
optimized the conditions for oxidation using CSO as compared to I2 and found a 
concentration o f  0.5 M in acetonitrile with a 3 minute oxidation time is as effective
as a 0.02 M I2 solution with a  30 second oxidation time.^ Therefore this oxidation 
procedure was used when preparing the 5-nitroindole primer for reactions. It was 
decided the sequences synthesized for thermodynamic studies did not have the 
excessive exposure as the primer sequence and resynthesis o f  the sequences was not 
necessary.
Ot:
Ipso SubstitutionAddition
Figure 6.1 Iodination o f 5-nitroindole
A series o f  test sequences were prepared in order to determine the extent o f  
substitution. Two sequences composed o f  4  natural bases with 5-nitroindole on the 
5’ end were prepared. One sequences was cleaved at the completion o f  the synthesis 
while a second synthesis was exposed to 35 more synthesis cycles yet no 
nucleotides were added. The two sequences were analyzed using MALDI-MS in
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THA matrix by Tracey Simmons. The analysis o f  these spectra did not provide 
conclusive evidence. Most often a  mass peak o f +100 units was found in the test 
sequence. This would indicate the replacement the nitro group with iodine as a 
sodium salt. These results need to be repeated using a more complete set o f  internal 
standards for calibration. Further testing o f  5-nitroindole nucleoside with exposure 
to 0.02 M I2 solution over several days again did not provide sufficient evidence to 
support either addition or substitution.
NMR and mass spectrometry o f  the resulting solution did not show any 
evidence o f  replacement or addition. Investigation into the automated capping cycle 
and the possibility o f  any residual capping agents affecting the oxidation step might 
offer an alternative explanation.
Table 6.1 MALDI-MS results for iodination test sequences
Sequence Oxidation M+H* M+H*
Condition calculated found
5’ CGTAQ 3’ 0.02M I2 solution 1515 1478
1486
1503
5 ’ CGTAQ 3’ 0.5M CSO solution 1515 1487
1504
5’ CGTAQ 3’ 
35 more cycles
0.02M I2 solution 1515 1488
1503
1583
5’ CGTAQ 3’ 
35 more cycles
0.5M CSO solution 1515 1478
1487
1504
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